Parent Cas#	Parent Chem. Name	Parent Smiles	Parent Map reliability	Parent Liver_Muta	Parent in vivo Liver predicted Clastogen	Parent Invitro predictions	Parent Mechanism	Parent Alert info	Parent ModelReliability	Parent Type of detoxification	Parent detoxification paths	Parent Parameter ranges	Parent Structural domain				Parent Total Domain	Metabolite in vivo Liver predicted Clastogen	Metabolite Invitro predictions	Metabolite Mechanism	Metabolite Alert info	Metabolite ModelReliability	Metabolite Type of detoxification	Summary Map reliability	Summary in vivo Liver predicted Clastogen	Summary Mechanism	Summary Alert info	Summary ModelReliability	Summary Type of detoxification	Summary detoxification paths	Summary Total Domain
													Parent Correct fragments Structural domain	Parent Incorrect fragments Structural domain	Parent Unknown fragments Structural domain	Parent Total Structural domain															
153661-28-0	(4-Sulfophenyl)acetic acid	OC(=O)Cc1ccc(S(O)(=O)=O)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3327-22-8	(s)-(-)-(3-Chloro-2-hydroxypropyl)trimethylammonium	CN{+}(C)(C)(.Cl{-})CC(O)CCl	0.6556	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	 	Out of domain	30.00%	0.00%	70.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	0.6556	in vivo Liver Clastogen positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	 	Out of Domain
2634-33-5	"1,2-Benzisothiazolinone"	O=C1c2ccccc2SN1	0.3851	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines;* 53. Carboxylic acid amines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	0.3851	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	Out of Domain
123-91-1	"1,4-Dioxane"	C1COCCO1	0.3175	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3175	in vivo Liver Clastogen negative	 	 	 	 	 	In domain
35079-97-1	"10,11-Dihydro-10,11-dihydroxycarbamazepine"	NC(=O)N1c2ccccc2C(O)C(O)c2ccccc12	0.3981	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.3981	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
29331-92-8	"10,11-Dihydro-10-hydroxycarbamazepine"	NC(=O)N1c2ccccc2CC(O)c2ccccc12	0.2038	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	11.11%	0.00%	88.89%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2038	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
865-86-1	"10:2 FTOH (1H,1H,2H,2H-perfluorododecan-1-ol)"	OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	0.1143	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	8.82%	0.00%	91.18%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	0.1143	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
35822-46-9	"1234678-HpCDD (1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin)"	Clc1cc2c(c(Cl)c1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2	0.5835	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5835	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
67562-39-4	"1234678-HpCDF (1,2,3,4,6,7,8-Heptachlorodibenzofuran)"	Clc1cc2c(c(Cl)c1Cl)Oc1c-2c(Cl)c(Cl)c(Cl)c1Cl	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
55673-89-7	"1234789-HpCDF (1,2,3,4,7,8,9-Heptachlorodibenzofuran)"	Clc1cc2c(c(Cl)c1Cl)-c1c(Cl)c(Cl)c(Cl)c(Cl)c1O2	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
39227-28-6	"123478-HxCDD (1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin)"	Clc1cc2c(cc1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2	0.5165	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5165	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
70648-26-9	"123478-HxCDF (1,2,3,4,7,8-Hexachlorodibenzofuran)"	Clc1cc2c(cc1Cl)-c1c(Cl)c(Cl)c(Cl)c(Cl)c1O2	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57653-85-7	"123678-HxCDD (1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin)"	Clc1cc2c(c(Cl)c1Cl)Oc1cc(Cl)c(Cl)c(Cl)c1O2	0.6429	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6429	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57117-44-9	"123678-HxCDF (1,2,3,6,7,8-Hexachlorodibenzofuran)"	Clc1cc2c(c(Cl)c1Cl)-c1cc(Cl)c(Cl)c(Cl)c1O2	0.8937	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.8937	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
19408-74-3	"123789-HxCDD (1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin)"	Clc1cc2c(c(Cl)c1Cl)Oc1c(cc(Cl)c(Cl)c1Cl)O2	0.6772	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6772	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
72918-21-9	"123789-HxCDF (1,2,3,7,8,9-Hexachlorodibenzofuran)"	Clc1cc2c(c(Cl)c1Cl)-c1c(cc(Cl)c(Cl)c1Cl)O2	0.906	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.906	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
40321-76-4	"12378-PeCDD (1,2,3,7,8-Pentachlorodibenzo-p-dioxin)"	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)c(Cl)c1O2	0.6247	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6247	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57117-41-6	"12378-PeCDF (1,2,3,7,8-Pentachlorodibenzofuran)"	Clc1cc2c(cc1Cl)-c1c(cc(Cl)c(Cl)c1Cl)O2	0.8333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.8333	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*-1-9	137Cs	 																													
57-91-0	17-alpha Estradiol	CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O	0.523	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	66.67%	6.67%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.523	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
57-63-6	17-alpha-Ethinylestradiol	CC12CCC3C(CCc4cc(O)ccc34)C1CCC2(O)C#C	0.3066	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	58.82%	0.00%	41.18%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3066	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
*50-63-6	17-beta Estradiol	CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O	0.523	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	66.67%	6.67%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.523	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
*-2-3	1998 WHO-TEQ for PCBs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Lower-bound	 																													
*-2-4	1998 WHO-TEQ for PCBs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Middle-bound	 																													
*-2-5	1998 WHO-TEQ for PCBs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Upper-bound	 																													
*-2-6	1998 WHO-TEQ for PCDD/Fs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Lower-bound	 																													
*-2-7	1998 WHO-TEQ for PCDD/Fs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Middle-bound	 																													
*-2-8	1998 WHO-TEQ for PCDD/Fs (1998 WorldHealthOrganisation-ToxicEquivalentQuantities) Upper-bound	 																													
95-14-7	1H-Benzotriazole	C1=CC=CC2C1=NNN=2	0.6176	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Quinoneimines	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.6176	in vivo Liver Clastogen negative	 	Quinoneimines	 	 	 	Out of Domain
90-15-3	1-Naphthol	Oc1cccc2ccccc12	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
71758-44-6	2-(2-(Chlorophenyl)amino)benzaldehyde	O=Cc1ccccc1Nc1ccccc1Cl	0.4435	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4435	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
615-22-5	2-(Methylthio)benzothiazole	CSC1=Nc2ccccc2S1	0.6123	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.6123	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
10222-01-2	"2,2-Dibromo-2-cyanoacetamide"	NC(=O)C(Br)(Br)C#N	0.3333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines	In domain	37.50%	0.00%	62.50%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	0.3333	in vivo Liver Clastogen negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of Domain
24650-42-8	"2,2-Dimethoxy-2-phenylacetophenon"	COC(c1ccccc1)(C(=O)c1ccccc1)OC	0.4762	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	55.56%	0.00%	44.44%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4762	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3033-77-0	"2,3-Epoxypropyltrimethylammonium"	CN{+}(C)(C)(.Cl{-})CC1CO1	0.4259	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.4259	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
94-75-7	"2,4-D"	OC(=O)COc1ccc(Cl)cc1Cl	0.578	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	62.50%	0.00%	37.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.578	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
615-05-4	"2,4-diaminoanisole"	COc1ccc(N)cc1N	0.5132	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	3. Single Ring Aromatic Amines	In domain	40.00%	20.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5132	in vivo Liver Clastogen negative	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	3. Single Ring Aromatic Amines	Out of Domain
88-63-1	"2,4-diaminobenzenesulfonic acid"	Nc1ccc(S(O)(=O)=O)c(N)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	Out of domain	14.29%	14.29%	71.43%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	Out of Domain
120-83-2	"2,4-Dichlorophenol"	Oc1ccc(Cl)cc1Cl	0.5961	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.5961	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
51-28-5	"2,4-Dinitrophenol"	Oc1ccc(N(=O)=O)cc1N(=O)=O	0.4419	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polynitroarenes	Undetermined (0 <n< 10)	 	 	In domain	75.00%	0.00%	25.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Nitroaniline Derivatives,Substituted Anilines"	Undetermined (0 <n< 10)	 	0.4419	in vivo Liver Clastogen positive	Interaction with DNA 	Polynitroarenes	Undetermined (0 <n< 10)	 	 	Out of Domain
110-44-1	"2,4-Hexadienoic acid (sorbic acid)"	CC=CC=CC(O)=O	0.2225	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2225	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
2008-58-4	"2,6-Dichlorobenzamide"	NC(=O)c1c(Cl)cccc1Cl	0.5348	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	Belongs to deacivated path	52. Carboxylic acid amines;53. Carboxylic acid amines	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	0.5348	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	 	Out of Domain
128-39-2	"2,6-Di-tert-butylphenol"	CC(C)(C)c1cccc(C(C)(C)C)c1O	0.1266	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Hydroxylated phenols	 	 	0.1266	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
87-62-7	"2,6-Xylidine"	Cc1cccc(C)c1N	0.3057	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines;7. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3057	in vivo Liver Clastogen negative	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines;7. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines	Out of Domain
1655-35-2	"2,7-Naphthalenedisulfonic acid"	O=S(=O)(c1ccc2ccc(S(=O)(=O)O{-}.[Na]{+})cc2c1)O{-}.[Na]{+}	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*-4-6	2005 WHO-TEQ for PCBs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Lower-bound	 																													
*-4-7	2005 WHO-TEQ for PCBs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Middle-bound	 																													
*-4-8	2005 WHO-TEQ for PCBs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Upper-bound	 																													
*-4-9	2005 WHO-TEQ for PCDD/Fs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Lower-bound	 																													
*-5-0	2005 WHO-TEQ for PCDD/Fs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Middle-bound	 																													
*-5-1	2005 WHO-TEQ for PCDD/Fs (2005 WorldHealthOrganisation-ToxicEquivalentQuantities) Upper-bound	 																													
60851-34-5	"234678-HxCDF (2,3,4,6,7,8-Hexachlorodibenzofuran)"	Clc1cc2c(c(Cl)c1Cl)Oc1c-2cc(Cl)c(Cl)c1Cl	0.8778	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.8778	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57117-31-4	"23478-PeCDF (2,3,4,7,8-Pentachlorodibenzofuran)"	Clc1cc2c(cc1Cl)-c1cc(Cl)c(Cl)c(Cl)c1O2	0.807	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.807	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
1746-01-6	2378-TCDD (Tetrachlorodibenzo-p-dioxin)	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2	0.5974	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5974	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
51207-31-9	"2378-TCDF (2,3,7,8-Tetrachlorodibenzofuran)"	Clc1cc2c(cc1Cl)-c1cc(Cl)c(Cl)cc1O2	0.7284	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.7284	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
93-08-3	2-Acetonaphthone / 2-acetylnaphthaline	CC(=O)c1ccc2ccccc2c1	0.4762	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4762	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
934-32-7	2-Aminobenzimidazole	NC1Nc2ccccc2N=1	0.4	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.4	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
117-62-4	"2-Aminonaphthalene-1,5-disulfonic acid"	Nc1ccc2c(S(O)(=O)=O)cccc2c1S(O)(=O)=O	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Fused-ring Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	"Fused-ring Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	Out of Domain
111-15-9	2-Ethoxyethyl acetate	CCOCCOC(C)=O	0.2599	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Specific Acetate Esters	 	 	 	In domain	88.89%	0.00%	11.11%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2599	in vivo Liver Clastogen negative	 	Specific Acetate Esters	 	 	 	Out of Domain
1241-94-7	2-ethylhexyl-diphenylphosphate	CCCCC(CC)COP(=O)(Oc1ccccc1)Oc1ccccc1	0.1282	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1282	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
5466-77-3	2-Ethylhexyl-p-methoxycinnamate	CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1	0.3266	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	56.25%	0.00%	43.75%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3266	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
90-43-7	2-Hydroxybiphenyl	Oc1ccccc1-c1ccccc1	0.1592	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	18. Phenolic Derivatives;26. Phenolic Derivatives	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1592	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
68011-66-5	2-Hydroxycarbamazepine	NC(=O)N1c2ccccc2C=Cc2cc(O)ccc12	0.4038	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4038	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
2814-20-2	2-Isopropyl-6-methyl-pyrimidin-4-ol	CC(C)c1nc(C)cc(O)n1	0.2215	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2215	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
5495-84-1	2-Isopropylthioxanthon (quantacure itx)	CC(C)c1ccc2c(c1)C(=O)c1ccccc1S2	0.1155	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Acridone, Thioxanthone, Xanthone and  Phenazine Derivatives"	Undetermined (0 <n< 10)	 	 	In domain	37.50%	12.50%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Acridone, Thioxanthone, Xanthone and  Phenazine Derivatives"	Undetermined (0 <n< 10)	 	0.1155	in vivo Liver Clastogen positive	Interaction with DNA 	"Acridone, Thioxanthone, Xanthone and  Phenazine Derivatives"	Undetermined (0 <n< 10)	 	 	Out of Domain
583-39-1	2-Mercapto benzimidazole	SC1Nc2ccccc2N=1	0.2843	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2843	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
149-30-4	2-Mercaptobenzothiazole	SC1=Nc2ccccc2S1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Thiols	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Thiols	 	 	 	Out of Domain
120-75-2	2-Methylbenzothiazole	CC1=Nc2ccccc2S1	0.7143	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.7143	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
120-18-3	2-Naphtalene sulfonic acid	OS(=O)(=O)c1ccc2ccccc2c1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
135-19-3	2-Naphthoic acid	Oc1ccc2ccccc2c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
95-76-1	"3,4-DCA (3,4-Dichloroaniline)"	Nc1ccc(Cl)c(Cl)c1	0.3304	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 7. Single Ring Aromatic Amines	In domain	25.00%	25.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	0.3304	in vivo Liver Clastogen negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 7. Single Ring Aromatic Amines	Out of Domain
107-54-0	"3,5-Dimethyl-1-hexyn-3-ol"	CC(C)CC(C)(O)C#C	0.5932	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5932	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
104-40-5	4-(para)-Nonylphenol	CCCCCCCCCc1ccc(O)cc1	0.0972	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	90.91%	0.00%	9.09%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.0972	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
838-88-0	"4,4'-Methylen-bis(2-methyl aniline)"	Cc1cc(Cc2ccc(N)c(C)c2)ccc1N	0.2423	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	7. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.2423	in vivo Liver Clastogen negative	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	Belongs to deacivated path	7. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines	Out of Domain
139-65-1	"4,4'-Thiodianiline"	Nc1ccc(Sc2ccc(N)cc2)cc1	0.2551	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	40.00%	0.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.2551	in vivo Liver Clastogen positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
122-80-5	4'-Aminoacetanilide	CC(=O)Nc1ccc(N)cc1	0.3666	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines;52. Carboxylic acid amines	In domain	83.33%	0.00%	16.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	0.3666	in vivo Liver Clastogen positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
83-07-8	4-Aminoantipyrin	CC1=C(N)C(=O)N(c2ccccc2)N1C	0.2962	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.2962	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
60-09-3	4-Aminoazobenzene	Nc1ccc(N=Nc2ccccc2)cc1	0.5754	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Anilines	 	Belongs to deacivated path	* 7. Single Ring Aromatic Amines	In domain	80.00%	0.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	0.5754	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	Out of Domain
2835-68-9	4-Aminobenzamide	Nc1ccc(C(N)=O)cc1	0.4021	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	Belongs to deacivated path	52. Carboxylic acid amines	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	0.4021	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	 	Out of Domain
1709-59-7	"4-Amino-N,N-dimethylbenzenesulfonamide"	CN(C)S(=O)(=O)c1ccc(N)cc1	0.3399	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	4. Single Ring Aromatic Amines	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.3399	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
63-05-8	"4-Androstene-3,17-dione"	CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2=O	0.2276	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	90.48%	0.00%	9.52%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2276	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
106-47-8	4-Chloroaniline	Nc1ccc(Cl)cc1	0.3161	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	7. Single Ring Aromatic Amines	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.3161	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
950-81-2	4-Formyl-antipyrine	CC1=C(C=O)C(=O)N(c2ccccc2)N1C	0.5538	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	Belongs to deacivated path	59. Vitaminic Naphthoquinone Derivatives	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.5538	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
26725-51-9	4-Hydroxybenzotriazole	Oc1cccc2c1N=NN2	0.2698	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2698	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
99-88-7	4-Isopropylaniline	CC(C)c1ccc(N)cc1	0.2526	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines;9. Single Ring Aromatic Amines	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	0.2526	in vivo Liver Clastogen negative	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines;8. Single Ring Aromatic Amines;9. Single Ring Aromatic Amines	Out of Domain
830-09-1	4-Methoxycinnamic acid	COc1ccc(C=CC(O)=O)cc1	0.5245	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5245	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
29878-31-7	4-Methyl-1-H-benzotriazole	Cc1cccc2c1NN=N2	0.5714	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5714	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
104-93-8	4-Methylanisole	Cc1ccc(OC)cc1	0.2103	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2103	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
36861-47-9	4-Methylbenzylidene camphor	Cc1ccc(C=C2C3CCC(C)(C2=O)C3(C)C)cc1	0.3903	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	29. Unsaturated Compounds;34. Unsaturated Compounds	In domain	35.71%	0.00%	64.29%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.3903	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
93-35-6	4-Methylcoumarin (umbelliferone)	Oc1ccc2C=CC(=O)Oc2c1	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
106-44-5	4-Methylphenol	Cc1ccc(O)cc1	0.3433	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	19. Phenolic Derivatives;21. Phenolic Derivatives	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3433	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	19. Phenolic Derivatives;21. Phenolic Derivatives	Out of Domain
26172-55-4	5-Chloro-2-methyl-4-isothiazolin-3-one	CN1C(=O)C=C(Cl)S1	0.1038	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloisothiazolinones	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	0.1038	in vivo Liver Clastogen positive	Interaction with DNA 	Haloisothiazolinones	Undetermined (0 <n< 10)	 	 	Out of Domain
1004-03-1	5-Fluorouracil	O=C1C(F)=CNC(=O)N1	1	in vivo Liver Clastogen negative	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	 	In domain	0.00%	100.00%	0.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	 	Out of Domain
136-85-6	5-Methyl-1-H-benzotriazole	CC1=CC2C(C=C1)=NNN=2	0.4789	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Quinoneimines	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.4789	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
120-53-6	6-Ethoxy-2-mercaptobenzothiazole	CCOc1ccc2c(c1)SC(S)=N2	0.3621	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Thiols	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Thiols,Substituted Phenols"	 	 	0.3621	in vivo Liver Clastogen negative	 	Thiols	 	 	 	Out of Domain
90-33-5	7-Hydroxy-4-methylcoumarin	CC1=CC(=O)Oc2cc(O)ccc12	0.3495	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Coumarins,Substituted Phenols"	 	Belongs to deacivated path	21. Phenolic Derivatives	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3495	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	 	Out of Domain
678-39-7	"8:2 FTOH (1H,1H,2H,2H-perfluorodecan-1-ol)"	OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	0.1143	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	10.71%	0.00%	89.29%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	0.1143	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
*-9-8	86Sr	[Sr]																													
*-9-9	87Sr	 																													
*-10-0	87Sr/86Sr	 																													
*-10-1	90Sr	 																													
83-15-8	AAA (4-Acetylaminoantipyrine)	CC1=C(NC(C)=O)C(=O)N(c2ccccc2)N1C	0.233	No data	in vivo Liver Clastogen negative	in vitro CA positive	 	 	 	Belongs to deacivated path	52. Carboxylic acid amines;53. Carboxylic acid amines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.233	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
83-32-9	Acenaphthene	C1Cc2cccc3cccc1c23	0.1351	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1351	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
208-96-8	Acenaphthylene	C1=Cc2cccc3cccc1c23	0.2283	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2283	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
55589-62-3	Acesulfame	CC1=CC(O{-}.K{+})=NS(=O)(=O)O1	0.1555	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1555	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
103-90-2	Acetaminophen (Paracetamol)	CC(=O)Nc1ccc(O)cc1	0.6889	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	 	In domain	83.33%	0.00%	16.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinoneimines,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.6889	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	 	 	Out of Domain
34256-82-1	Acetochlor	CCc1cccc(C)c1N(COCC)C(=O)CCl	0.1894	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	53.85%	0.00%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha-Activated Haloalkanes,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.1894	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
21312-10-7	Acetyl-Sulfamethoxazole	CC1=CC(NS(=O)(=O)c2ccc(NC(C)=O)cc2)=NO1	0.2226	No data	in vivo Liver Clastogen negative	in vitro CA positive	 	 	 	Belongs to deacivated path	52. Carboxylic acid amines	In domain	26.67%	0.00%	73.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	0.2226	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	Out of Domain
573-89-7	Acid orange 7 (free acid)	Oc1ccc2ccccc2c1N=Nc1ccc(S(O)(=O)=O)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	11.11%	0.00%	88.89%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Fused-ring Primary Aromatic Amines	Undetermined (0 <n< 10)	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Fused-ring Primary Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
74070-46-5	Aclonifen	Nc1c(N(=O)=O)ccc(Oc2ccccc2)c1Cl	0.3926	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	Belongs to deacivated path	7. Single Ring Aromatic Amines	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3926	in vivo Liver Clastogen negative	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	Belongs to deacivated path	7. Single Ring Aromatic Amines	Out of Domain
13171-00-1	ADBI (celestolide)	CC(=O)c1cc(C(C)(C)C)cc2c1CCC2(C)C	0.1214	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	61.54%	0.00%	38.46%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1214	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1506-02-1	AHTN (Tonalide)	CC1CC(C)(C)c2cc(C(C)=O)c(C)cc2C1(C)C	0.1413	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	57.14%	0.00%	42.86%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1413	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
15972-60-8	Alachlor	CCc1cccc(CC)c1N(COC)C(=O)CCl	0.3429	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	53.85%	0.00%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha-Activated Haloalkanes,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.3429	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
319-84-6	alpha-Hexachlorocyclohexane (alpha-HCH)	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	0.5329	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	0.5329	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
28981-97-7	Alprazolam	CC1=NN=C2CN=C(c3ccccc3)c3cc(Cl)ccc3N12	0.126	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.126	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
665-66-7	Amantadine	Cl_NC12CC3CC(C1)CC(C2)C3	0.963	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	81.82%	0.00%	18.18%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.963	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
123-69-3	Ambrettolide	O=C1CCCCCC=CCCCCCCCCO1	0.2185	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	11.11%	22.22%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.2185	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
834-12-8	Ametryn	CCNc1nc(NC(C)C)nc(SC)n1	0.141	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.00%	40.00%	30.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.141	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
117-96-4	Amidotrizoic / Diatrizoic acid	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(O)=O)c1I	0.2	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	 	 	In domain	53.33%	0.00%	46.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.2	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
14798-03-9	Ammonium (NH4-N)	N{+}																													
1066-51-9	AMPA (Aminomethylphosphonic acid)	NCP(O)(O)=O	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
53-41-8	Androsterone	CC12CCC(O)CC1CCC1C2CCC2(C)C1CCC2=O	0.3998	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	85.71%	0.00%	14.29%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3998	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
191-26-4	Anthanthrene	c1ccc2ccc3cc4cccc5ccc6cc1c2c3c6c45	0	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
120-12-7	Anthracene	c1cccc2cc3ccccc3cc12	0.0719	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.0719	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
7440-36-0	Antimony (Sb) - total	[Sb]																													
7440-38-2	Arsenic (As) - dissolved	[As]																													
7440-38-2	Arsenic (As) - total	[As]_[As]																													
216667-08-2	"ASB-14 (3-[N,N-Dimethyl(3-myristoylaminopropyl)ammonio]propanesulfonate) / Amidosulfobetaine-14"	CCCCCCCCCCCCCC(=O)NCCCN{+}(C)(C)CCCS(=O)(=O)O{-}	0.3522	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	65.52%	0.00%	34.48%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3522	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
22839-47-0	Aspartame	COC(=O)C(Cc1ccccc1)NC(=O)C(N)CC(O)=O	0.2476	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 53. Carboxylic acid amines	In domain	56.25%	6.25%	37.50%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2476	in vivo Liver Clastogen negative	 	 	 	Belongs to deacivated path	* 53. Carboxylic acid amines	Out of Domain
29122-68-7	Atenolol	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	0.1712	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	78.57%	7.14%	14.29%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1712	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
68140-48-7	ATII (Traseolide)	CC(C)C1C(C)C(C)(C)c2cc(C)c(C(C)=O)cc12	0.142	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.142	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1912-24-9	Atrazine	CCNc1nc(NC(C)C)nc(Cl)n1	0.1278	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	66.67%	0.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1278	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
2642-71-9	Azinophos-ethyl	CCOP(=S)(OCC)SCN1C(=O)c2ccccc2N=N1	0.0995	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0995	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
86-50-0	Azinophos-methyl	COP(=S)(OC)SCN1C(=O)c2ccccc2N=N1	0.0995	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0995	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
*-13-5	Azoxystrobin	COC=C(c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1)C(=O)OC	0.3025	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	6.67%	0.00%	93.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	0.3025	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	Out of Domain
189084-64-8	"BDE-100 (2,2,4,4,6-Pentabromodiphenylether)"	Brc1ccc(Oc2c(Br)cc(Br)cc2Br)c(Br)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
68631-49-2	"BDE-153 (2,2,4,4,5,5-Hexabromodiphenylether)"	Brc1cc(Br)c(Br)cc1Oc1cc(Br)c(Br)cc1Br	0.5538	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5538	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
207122-15-4	"BDE-154 (2,2,4,4,5,6-Hexabromodiphenylether)"	Brc1cc(Br)cc(Br)c1Oc1cc(Br)c(Br)cc1Br	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
207122-16-5	"BDE-183 (2,2,3,4,4,5,6-Heptabromodiphenylether)"	Brc1cc(Br)c(Br)cc1Oc1c(Br)cc(Br)c(Br)c1Br	0.6762	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.6762	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1163-19-5	BDE-209 (Decabromodiphenylether)	Brc1c(Br)c(Br)c(Br)c(Br)c1Oc1c(Br)c(Br)c(Br)c(Br)c1Br	0.5286	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5286	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
41318-75-6	"BDE-28 (2,4,4-Tribromodiphenylether)"	Brc1ccc(Oc2ccc(Br)cc2Br)cc1	0.9091	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.9091	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
5436-43-1	"BDE-47 (2,2,4,4-Tetrabromodiphenylether)"	Brc1ccc(Oc2ccc(Br)cc2Br)c(Br)c1	0.9091	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.9091	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
182346-21-0	"BDE-85 (2,2,3,4,4-Pentabromodiphenylether)"	Brc1ccc(Oc2ccc(Br)c(Br)c2Br)c(Br)c1	0.9423	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.9423	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
60348-60-9	"BDE-99 (2,2,4,4,5-Pentabromodiphenylether)"	Brc1ccc(Oc2cc(Br)c(Br)cc2Br)c(Br)c1	0.9091	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.9091	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
22781-23-3	Bendiocarb	CC1(C)Oc2cccc(OC(=O)NC)c2O1	0.3285	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3285	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
25057-89-0	Bentazon	CC(C)N1C(=O)c2ccccc2NS1(=O)=O	0.0971	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	 	0.0971	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
98-11-3	Benzenesulfonic acid	OS(=O)(=O)c1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
121-54-0	Benzethonium	CC(C)(C)CC(C)(C)c1ccc(OCCOCCN{+}(C)(C)(.Cl{-})Cc2ccccc2)cc1	0.3333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	52.38%	0.00%	47.62%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3333	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
56-55-3	Benzo(a)anthracene	c1cccc2ccc3cc4ccccc4cc3c12	0.1102	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1102	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
50-32-8	Benzo(a)pyrene	c1cccc2cc3ccc4cccc5ccc(c12)c3c45	0.0669	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Epoxides and Aziridines,Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives"	Undetermined (0 <n< 10)	 	0.0669	in vivo Liver Clastogen positive	Interaction with DNA 	"Epoxides and Aziridines,Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives"	Undetermined (0 <n< 10)	 	 	Out of Domain
205-99-2	Benzo(b)fluoranthene	c1cccc2cc3c4ccccc4c4cccc(c12)c34	0.1277	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1277	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
243-17-4	Benzo(b)fluorene	C1c2ccccc2-c2cc3ccccc3cc12	0.1529	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1529	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
205-43-6	"Benzo(b)naphtho(1,2-d)thiophene"	c1cccc2ccc3c(c12)-c1ccccc1S3	0.138	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.138	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
192-97-2	Benzo(e)pyrene	c1cccc2c1c1cccc3ccc4cccc2c4c13	0.078	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0.078	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
203-12-3	"Benzo(g,h,i)fluoranthene"	c1ccc2ccc3ccc4cccc5c1c2c3c45	0	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0	in vivo Liver Clastogen negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	Out of Domain
191-24-2	"Benzo(g,h,i)perylene"	c1ccc2ccc3ccc4ccc5cccc6c1c2c3c4c56	0	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
205-82-3	Benzo(j)fluoranthene	c1cccc2ccc3c4cccc5cccc(c3c12)c45	0.1003	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1003	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
207-08-9	Benzo(k)fluoranthene	c1cccc2cc3c4cccc5cccc(c3cc12)c45	0.1003	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1003	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
119-61-9	Benzophenone	O=C(c1ccccc1)c1ccccc1	0.4762	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4762	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
131-57-7	Benzophenone-3 (2-Hydroxy-4-methoxy-benzophenone)	COc1ccc(C(=O)c2ccccc2)c(O)c1	0.4535	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 23. Phenolic Derivatives	In domain	42.86%	0.00%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4535	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
4065-45-6	Benzophenone-4	COc1cc(O)c(C(=O)c2ccccc2)cc1S(O)(=O)=O	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	18.18%	9.09%	72.73%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
95-16-9	Benzothiazole	c1cccc2c1N=CS2	0.051	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.051	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
613-62-7	Benzyl-2-naphthylether (phenylmethoxynaphthaline)	C(c1ccccc1)Oc1ccc2ccccc2c1	0.1652	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.1652	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
139-07-1	Benzyldimethyldodecylammonium	CCCCCCCCCCCCN{+}(C)(C)(.Cl{-})Cc1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
122-18-9	Benzyldimethylhexadecylammonium	CCCCCCCCCCCCCCCCN{+}(C)(C)(.Cl{-})Cc1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	72.73%	0.00%	27.27%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
50-28-2	Beta-estradiol	CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O	0.523	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	66.67%	6.67%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.523	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
319-85-7	beta-Hexaxchlorocyclohexane (beta-HCH)	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	0.5329	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	0.5329	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
63659-18-7	Betaxolol	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	0.1712	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	64.71%	5.88%	29.41%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1712	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
41859-67-0	Bezafibrate	CC(C)(C(O)=O)Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1	0.1987	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines	In domain	80.00%	0.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	 	0.1987	in vivo Liver Clastogen negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of Domain
128-37-0	BHT (Dibutylhydroxytoluene)	Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	0.3697	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 19. Phenolic Derivatives;* 21. Phenolic Derivatives	In domain	54.55%	0.00%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	0.3697	in vivo Liver Clastogen negative	 	Substituted Phenols	 	Belongs to deacivated path	* 19. Phenolic Derivatives;* 21. Phenolic Derivatives	Out of Domain
42576-02-3	Bifenox	COC(=O)c1cc(Oc2ccc(Cl)cc2Cl)ccc1N(=O)=O	0.4677	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	 	 	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	 	0.4677	in vivo Liver Clastogen positive	Interaction with DNA 	Nitrobiphenyls and Bridged Nitrobiphenyls	Undetermined (0 <n< 10)	 	 	Out of Domain
92-52-4	Biphenyl	c1ccccc1-c1ccccc1	0.1126	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1126	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
80-07-9	Bis(4-chlorophenyl)sulfone	O=S(=O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1	0.3943	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3943	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
7440-69-9	Bismuth (Bi) - total	[Bi]																													
66722-44-9	Bisoprolol	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	0.1712	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	11.11%	22.22%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1712	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
80-05-7	Bisphenol A	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	57.14%	0.00%	42.86%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
620-92-8	Bisphenol F	Oc1ccc(Cc2ccc(O)cc2)cc1	0.4671	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.4671	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	20. Phenolic Derivatives;26. Phenolic Derivatives	Out of Domain
80-09-1	Bisphenol S	Oc1ccc(S(=O)(=O)c2ccc(O)cc2)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
188425-85-6	Boscalid	O=C(c1cccnc1Cl)Nc1ccccc1-c1ccc(Cl)cc1	0.2799	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	Belongs to deacivated path	* 52. Carboxylic acid amines;53. Carboxylic acid amines	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2799	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
1812-30-2	Bromazepam	O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1	0.1974	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1974	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
1689-84-5	Bromoxynil	N#Cc1cc(Br)c(O)c(Br)c1	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
30007-47-7	"Bronidox (5-brom-5-nitro-1,3-dioxan)"	O=N(=O)C1(Br)COCOC1	0	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	20.00%	30.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
941-57-1	BTSA (2-Benzothiazolsulfonic acid)	OS(=O)(=O)C1=Nc2ccccc2S1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
2752-95-6	Butyl diphenylphosphate	CCCCOP(=O)(Oc1ccccc1)Oc1ccccc1	0.1393	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	54.55%	0.00%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1393	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
94-26-8	Butyl paraben	CCCCOC(=O)c1ccc(O)cc1	0.356	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Arenecarboxylic Acid Esters	Undetermined (0 <n< 10)	Belongs to deacivated path	21. Phenolic Derivatives;25. Phenolic Derivatives	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	Belongs to deacivated path	0.356	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Arenecarboxylic Acid Esters	Undetermined (0 <n< 10)	Belongs to deacivated path	21. Phenolic Derivatives;25. Phenolic Derivatives	Out of Domain
85535-84-8	C10-C13 Chloroalkanes	CCCCCC(Cl)CCCC	0.2461	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	81.82%	0.00%	18.18%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2461	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7440-43-9	Cadmium (Cd) - dissolved	[Cd]																													
7440-43-9	Cadmium (Cd) - total	[Cd]_[Cd]																													
58-08-2	Caffeine	CN1C=NC2=C1C(=O)N(C)C(=O)N2C	0.0279	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	0.0279	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	 	Out of Domain
7440-70-2	Calcium (Ca)  total	[Ca]																													
7440-70-2	Calcium (Ca)  total	[Ca]_[Ca]																													
976-71-6	Canrenone	CC12CCC3C(C=CC4=CC(=O)CCC34C)C1CCC21CCC(=O)O1	0.1925	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Four-and Five-Membered Lactones,alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	92.00%	0.00%	8.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Epoxides and Aziridines,Four-and Five-Membered Lactones"	 	 	0.1925	in vivo Liver Clastogen negative	 	"Four-and Five-Membered Lactones,alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	Out of Domain
154361-50-9	Capecitabine	CCCCCOC(=O)NC1C(F)=CN(C2C(O)C(O)C(C)O2)C(=O)N=1	0.1195	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	48.00%	0.00%	52.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	0.1195	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
298-46-4	Carbamazepine	NC(=O)N1c2ccccc2C=Cc2ccccc12	0.2301	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2301	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
63-25-2	Carbaryl	CNC(=O)Oc1cccc2ccccc12	0.3285	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3285	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
10605-21-7	Carbendazim	COC(=O)NC1Nc2ccccc2N=1	0.3193	in vivo Liver Clastogen positive	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	0.3193	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain
128639-02-1	Carfentrazon-ethyl	CCOC(=O)C(Cl)Cc1cc(N2C(=O)N(C(F)F)C(C)=N2)c(F)cc1Cl	0.4017	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	alpha-Activated Haloalkanes	 	 	 	In domain	19.05%	4.76%	76.19%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	0.4017	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
33704-61-9	Cashmeran	CC1C(C)(C)C2CCCC(=O)C=2C1(C)C	0.1417	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	Belongs to deacivated path	* 29. Unsaturated Compounds	In domain	46.67%	0.00%	53.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	Belongs to deacivated path	0.1417	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	Belongs to deacivated path	* 29. Unsaturated Compounds	Out of Domain
13171-00-1	Celestolide	CC(=O)c1cc(C(C)(C)C)cc2c1CCC2(C)C_R	0.1791	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	61.54%	0.00%	38.46%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1791	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
83881-51-0	Cetirizine	OC(=O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	0.2692	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	64.71%	11.76%	23.53%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2692	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
56-75-7	Chloramphenicol	OCC(C(O)c1ccc(N(=O)=O)cc1)NC(=O)C(Cl)Cl	0.2936	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	p-Substituted Mononitrobenzenes	Undetermined (0 <n< 10)	 	 	In domain	46.67%	0.00%	53.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	p-Substituted Mononitrobenzenes	Undetermined (0 <n< 10)	 	0.2936	in vivo Liver Clastogen positive	Interaction with DNA 	p-Substituted Mononitrobenzenes	Undetermined (0 <n< 10)	 	 	Out of Domain
470-90-6	Chlorfenvinphos	CCOP(=O)(OCC)OC(=CCl)c1ccc(Cl)cc1Cl	0.3325	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	26.67%	0.00%	73.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.3325	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
1698-60-8	Chloridazon	NC1C=NN(c2ccccc2)C(=O)C=1Cl	0.375	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.375	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
6339-19-1	Chloridazon-desphenyl	NC1C=NNC(=O)C=1Cl	0.4444	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	0.4444	in vivo Liver Clastogen positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
*-20-5	Chloridazon-methyl-desphenyl	CN1C(=O)C(Cl)=C(N)C=N1	0.1984	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	0.1984	in vivo Liver Clastogen positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
16887-00-6	Chlorides (Cl-)	Cl{-}																													
7003-89-6	Chlormequat	CN{+}(C)(C)CCCl	0.4543	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Nitrogen Mustards	Undetermined (0 <n< 10)	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Nitrogen Mustards	Undetermined (0 <n< 10)	 	0.4543	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Nitrogen Mustards	Undetermined (0 <n< 10)	 	 	Out of Domain
120-32-1	Chlorophene	Oc1ccc(Cl)cc1Cc1ccccc1	0.5087	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	40.00%	0.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5087	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	20. Phenolic Derivatives;26. Phenolic Derivatives	Out of Domain
*-20-9	Chlorophyll-a (phytoplankton - fluorescence)	 																													
1897-45-6	Chlorothalonil	N#Cc1c(Cl)c(C#N)c(Cl)c(Cl)c1Cl	0.6667	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	 	 	 	 	 	 	0.6667	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1982-47-4	Chloroxuron	CN(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1	0.1044	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1044	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
2921-88-2	Chlorpyrifos	CCOP(=S)(OCC)Oc1c(Cl)cc(Cl)c(Cl)n1	0.3627	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	15.38%	0.00%	84.62%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.3627	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
64902-72-3	Chlorsulfuron	Cc1nc(NC(=O)NS(=O)(=O)c2ccccc2Cl)nc(OC)n1	0.2918	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	 	In domain	7.69%	0.00%	92.31%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2918	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
15545-48-9	Chlortoluron	Cc1ccc(NC(=O)N(C)C)cc1Cl	0.1118	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1118	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57-88-5	Cholesterol	CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C	0.3075	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	78.57%	0.00%	21.43%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.3075	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
81-25-4	Cholic acid	CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	0.2755	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	75.86%	3.45%	20.69%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2755	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7440-47-3	Chromium (Cr) - dissolved	[Cr]																													
7440-47-3	Chromium (Cr) - total	[Cr]_[Cr]																													
218-01-9	Chrysene	c1cccc2ccc3c4ccccc4ccc3c12	0.1124	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1124	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
85721-33-1	Ciprofloxacin	OC(=O)C1=CN(C2CC2)c2cc(N3CCNCC3)c(F)cc2C1=O	0.4016	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	In domain	10.53%	0.00%	89.47%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.4016	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
59729-33-8	Citalopram	CN(C)CCCC1(c2ccc(F)cc2)c2ccc(C#N)cc2CO1	0.1414	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	42.86%	7.14%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1414	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
5392-40-5	Citral (Citral A=Geranial + Citral B=Neral)	CC(C)=CCCC(C)=CC=O	0.2099	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alfa,Beta-Unsaturated Aldehydes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	0.2099	in vivo Liver Clastogen negative	 	"Alfa,Beta-Unsaturated Aldehydes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	Out of Domain
106-23-0	Citronellal	CC(CCC=C(C)C)CC=O	0.8065	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	27.27%	0.00%	72.73%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.8065	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
81103-11-9	Clarithromycin	CCC1C(C)(O)C(O)C(C)C(=O)C(C)CC(C)(OC)C(OC2C(O)C(N(C)C)CC(C)O2)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(=O)O1	0.1772	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	65.38%	1.92%	32.69%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1772	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
37148-27-9	Clenbuterol	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	Belongs to deacivated path	* 1. Single Ring Aromatic Amines	Out of Domain
22316-47-8	Clobazam	CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc12	0.1825	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	63.64%	0.00%	36.36%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1825	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
882-09-7	Clofibric acid	CC(C)(C(O)=O)Oc1ccc(Cl)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	77.78%	0.00%	22.22%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
81777-89-1	Clomazone	CC1(C)CON(Cc2ccccc2Cl)C1=O	0.2955	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2955	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
1622-61-3	Clonazepam	O=C1CN=C(c2ccccc2Cl)c2cc(N(=O)=O)ccc2N1	0.4394	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	Belongs to deacivated path	53. Carboxylic acid amines	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	 	0.4394	in vivo Liver Clastogen positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	 	 	Out of Domain
23593-75-1	Clotrimazol	Clc1ccccc1C(c1ccccc1)(c1ccccc1)N1C=CN=C1	0.3778	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.3778	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7440-48-4	Cobalt (Co) - total	[Co]																													
*-23-2	Conductivity	 																													
7440-50-8	Copper (Cu) - dissolved	[Cu]																													
7440-50-8	Copper (Cu) - total	[Cu]_[Cu]																													
360-68-9	Coprostanol	CC(C)CCCC(C)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C	0.3959	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	92.86%	0.00%	7.14%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3959	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
191-07-1	Coronene	c1cc2ccc3ccc4ccc5ccc6ccc1c1c2c3c4c5c61	0	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
53-06-5	Cortisone	CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO	0.2097	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	Belongs to deacivated path	29. Unsaturated Compounds	In domain	84.62%	0.00%	15.38%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2097	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
486-56-6	Cotinine	CN1C(c2cccnc2)CCC1=O	0.2419	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2419	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
60-27-5	Creatinine	CN1CC(=O)N=C1N	0.1796	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.1796	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
483-63-6	Crotamiton	CCN(c1ccccc1C)C(=O)C=CC	0.4765	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4765	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
28159-98-0	Cybutryne	CC(C)(C)Nc1nc(NC2CC2)nc(SC)n1	0.0322	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	8.33%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0322	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
100-88-9	Cyclamate (as N-Cyclohexylsulfamic acid)	OS(=O)(=O)NC1CCCCC1	0.1905	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	45.45%	0.00%	54.55%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1905	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
27208-37-3	"Cyclopenta(c,d)pyrene (CPP)"	C1=Cc2ccc3ccc4cccc5cc1c2c3c45	0.1651	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1651	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
50-18-0	Cyclophosphamide	O=P1(N(CCCl)CCCl)NCCCO1	0.069	in vivo Liver Clastogen positive	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Nitrogen Mustards	Undetermined (0 <n< 10)	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Nitrogen and Sulfur Mustards,Nitrogen Mustards"	Undetermined (0 <n< 10)	 	0.069	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Nitrogen Mustards	Undetermined (0 <n< 10)	 	 	In domain
52315-07-8	Cypermethrin	CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1	0.2389	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Haloalkenes with Electron-Withdrawing Groups 	 	 	 	In domain	27.78%	5.56%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	0.2389	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	 	Out of Domain
65854-78-6	D5-Oxazepam	H{LBL2}c1c(H{LBL2})c(H{LBL2})c(H{LBL2})c(H{LBL2})c1C1c2cc(Cl)ccc2NC(=O)C(O)N=1	0.3333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	0.3333	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
486-66-8	Daidzein	Oc1ccc(C2=COc3cc(O)ccc3C2=O)cc1	0.6981	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	In domain	11.11%	0.00%	88.89%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.6981	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
08-02-27	"DCPU (3,4-Dichlorophenylurea)"	NC(=O)Nc1ccc(Cl)c(Cl)c1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
134-62-3	"DEET (N,N-Diethyl-m-toluamid)"	CCN(CC)C(=O)c1cccc(C)c1	0.1651	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	44.44%	0.00%	55.56%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1651	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
319-86-8	delta-Hexachlorocyclohexane (delta-HCH)	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	0.5329	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	0.5329	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
52918-63-5	Deltamethrin	CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1	0.2389	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalkenes with Electron-Withdrawing Groups 	Undetermined (0 <n< 10)	 	 	In domain	27.78%	5.56%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalkenes with Electron-Withdrawing Groups 	Undetermined (0 <n< 10)	 	0.2389	in vivo Liver Clastogen positive	Interaction with DNA 	Haloalkenes with Electron-Withdrawing Groups 	Undetermined (0 <n< 10)	 	 	Out of Domain
6190-65-4	Desethylatrazine	CC(C)Nc1nc(N)nc(Cl)n1	0.1109	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.57%	42.86%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1109	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
30125-63-4	Desethylterbutylazine	CC(C)(C)Nc1nc(N)nc(Cl)n1	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	37.50%	12.50%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1007-28-9	Desisopropylatrazine	CCNc1nc(N)nc(Cl)n1	0.3281	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	16.67%	50.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3281	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
50-02-2	Dexamethasone	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	0.4309	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	29. Unsaturated Compounds;34. Unsaturated Compounds	In domain	57.14%	3.57%	39.29%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.4309	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
117-81-7	Di(2-ethylhexyl)phthalate (DEHP)	CCCCC(CC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC	0.1737	in vivo Liver Clastogen negative	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1737	in vivo Liver Clastogen negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain
439-14-5	Diazepam	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc12	0.0592	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0592	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain
333-41-5	Diazinone	CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1	0.2055	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.2055	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
215-58-7	"Dibenzo(a,c)anthracene"	c1cccc2cc3c4ccccc4c4ccccc4c3cc12	0.1405	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Epoxides and Aziridines,Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives"	Undetermined (0 <n< 10)	 	0.1405	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
53-70-3	"Dibenzo(a,h)anthracene"	c1cccc2ccc3cc4c5ccccc5ccc4cc3c12	0.0906	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Epoxides and Aziridines,Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives"	Undetermined (0 <n< 10)	 	0.0906	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
2528-36-1	Dibutyl phenylphosphate	CCCCOP(=O)(OCCCC)Oc1ccccc1	0.171	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.171	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
1002-53-5	Dibutyltin-cation	CCCC[Sn]CCCC	0.2084	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2084	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
62-73-7	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl	0.3111	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	0.3111	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
15307-86-5	Diclofenac	OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	0.5984	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5984	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*-26-5	Dicofol	OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)C(Cl)(Cl)Cl	0.1646	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	0.1646	in vivo Liver Clastogen negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	Out of Domain
2390-68-3	Didecyldimethylammonium	CCCCCCCCCCN{+}(C)(C)(.Br{-})CCCCCCCCCC	0.2001	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	75.00%	0.00%	25.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2001	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
56-53-1	Diethylstilbestrol	CCC(=C(CC)c1ccc(O)cc1)c1ccc(O)cc1	0.3151	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;19. Phenolic Derivatives	In domain	40.00%	20.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3151	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	19. Phenolic Derivatives	Out of Domain
83164-33-4	Diflufenican	O=C(c1cccnc1Oc1cccc(C(F)(F)F)c1)Nc1ccc(F)cc1F	0.1842	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Geminal Polyhaloalkane Derivatives,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 53. Carboxylic acid amines;53. Carboxylic acid amines	In domain	7.69%	0.00%	92.31%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1842	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
111-96-6	Diglyme	COCCOCCOC	0.0665	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0665	in vivo Liver Clastogen negative	 	 	 	 	 	In domain
50563-36-5	Dimetachlor	Cc1cccc(C)c1N(CCOC)C(=O)CCl	0.1745	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha-Activated Haloalkanes,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.1745	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
60-51-5	Dimethoate	CNC(=O)CSP(=S)(OC)OC	0.0548	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0548	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
58-15-1	Dimethylaminophenazone	CC1=C(N(C)C)C(=O)N(c2ccccc2)N1C	0.078	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.078	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
107-64-2	Dimethyldioctadecylammonium	CCCCCCCCCCCCCCCCCCN{+}(C)(C)(.Cl{-})CCCCCCCCCCCCCCCCCC	0.2001	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	85.00%	0.00%	15.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2001	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
84-74-2	Di-n-butylphthalate (DBP)	CCCCOC(=O)c1ccccc1C(=O)OCCCC	0.1049	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain	86.67%	0.00%	13.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	0.1049	in vivo Liver Clastogen positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
94410-05-6	Dioctyltin-cation	CCCCCCCC[Sn]CCCCCCCC	0.1677	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	82.35%	0.00%	17.65%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1677	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
838-85-7	Diphenyl phosphate	OP(=O)(Oc1ccccc1)Oc1ccccc1	0.1498	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1498	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
122-39-4	Diphenylamine	c1ccccc1Nc1ccccc1	0.3333	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	0.3333	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
1135-99-5	Diphenyltin-cation	Cl[Sn](Cl)(c1ccccc1)c1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
64-85-7	Dissolved organic carbon (DOC)																														
*-28-0	Dissolved oxygen	 																													
298-04-4	Disulfoton	CCOP(=S)(OCC)SCCSCC	0.1002	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	21.43%	0.00%	78.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.1002	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
330-54-1	Diuron	CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1	0.0965	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	11.11%	0.00%	88.89%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0965	in vivo Liver Clastogen negative	 	N-Substituted Aromatic Amines	 	 	 	Out of Domain
27176-87-0	Dodecylbenzenesulfonic acid	CCCCCCCCCCCCc1ccccc1S(O)(=O)=O	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	64.71%	0.00%	35.29%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
151-21-3	Dodecylsulfonic acid	CCCCCCCCCCCCOS(=O)(=O)O{-}.[Na]{+}	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	61.11%	0.00%	38.89%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
60-00-4	EDTA	OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	50.00%	10.00%	40.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1241-94-7	EHDP (2-Ethylhexyl diphenyl phosphate)	CCCCC(CC)COP(=O)(Oc1ccccc1)Oc1ccccc1_R	0.1733	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1733	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
115-29-7	"Endosulfan (alpha, beta)"	O=S1OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	31.58%	0.00%	68.42%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
93106-60-6	Enrofloxacin	CCN1CCN(c2cc3c(cc2F)C(=O)C(C(O)=O)=CN3C2CC2)CC1	0.4016	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	In domain	23.81%	4.76%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.4016	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
481-29-8	Epiandrosteron	CC12CCC(O)CC1CCC1C2CCC2(C)C1CCC2=O	0.3998	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	85.71%	0.00%	14.29%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3998	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
135319-73-2	Epoxiconazole	Fc1ccc(C2(CN3C=NC=N3)C(c3ccccc3Cl)O2)cc1	0.7725	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.7725	in vivo Liver Clastogen negative	 	Epoxides and Aziridines	 	 	 	Out of Domain
114-07-8	Erythromycin	CCC1C(C)(O)C(O)C(C)C(=O)C(C)CC(C)(O)C(OC2C(O)C(N(C)C)CC(C)O2)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(=O)O1	0.2141	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	64.71%	1.96%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2141	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
51630-58-1	Esfenvalerate	CC(C)C(c1ccc(Cl)cc1)C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1	0.2192	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	6.67%	53.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	0.2192	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	 	Out of Domain
50-27-1	Estriol	CC12CCC3C(CCc4cc(O)ccc34)C1CC(O)C2O	0.3396	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	68.75%	0.00%	31.25%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3396	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	Out of Domain
53-16-7	Estrone	CC12CCC3C(CCc4cc(O)ccc34)C1CCC2=O	0.264	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;26. Phenolic Derivatives	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.264	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
563-12-2	Ethion	CCOP(=S)(OCC)SCSP(=S)(OCC)OCC	0.0576	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	21.05%	0.00%	78.95%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0576	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
*26255-79-6	Ethofumesate	CCOC1C(C)(C)c2cc(OS(C)(=O)=O)ccc2O1	0.3333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	57.14%	7.14%	35.71%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3333	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1077-56-1	Ethyl tosylamide	CCNS(=O)(=O)c1ccccc1C	0.3293	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3293	in vivo Liver Clastogen negative	 	Arenesulphonamides	 	 	 	Out of Domain
104-66-5	"Ethyleneglycol dipenylether (1,2-diphenoxyethane)"	C(COc1ccccc1)Oc1ccccc1	0.0664	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.0664	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
*-29-9	Ethylparaben	CCOC(=O)c1ccc(O)cc1	0.4583	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Arenecarboxylic Acid Esters	Undetermined (0 <n< 10)	Belongs to deacivated path	25. Phenolic Derivatives	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	0.4583	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Arenecarboxylic Acid Esters	Undetermined (0 <n< 10)	Belongs to deacivated path	25. Phenolic Derivatives	Out of Domain
31637-97-5	Etofibrate	CC(C)(C(=O)OCCOC(=O)c1cccnc1)Oc1ccc(Cl)cc1	0.3151	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	0.3151	in vivo Liver Clastogen positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
97-53-0	Eugenol (2-Methoxy-4-(2-propen-1-yl)phenol)	COc1cc(CC=C)ccc1O	0.3703	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	19. Phenolic Derivatives;20. Phenolic Derivatives;22. Phenolic Derivatives;23. Phenolic Derivatives	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	Belongs to deacivated path	0.3703	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	19. Phenolic Derivatives;20. Phenolic Derivatives;22. Phenolic Derivatives;23. Phenolic Derivatives	Out of Domain
1672-58-8	FAA (4-Formylaminoantipyrine)	CC1=C(NC=O)C(=O)N(c2ccccc2)N1C	0.1072	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.1072	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
42017-89-0	Fenobric acid	CC(C)(C(O)=O)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
49562-28-9	Fenofibrate	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	0.1468	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1468	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
31879-05-7	Fenoprofene	CC(c1cccc(Oc2ccccc2)c1)C(O)=O	0.3332	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	37.50%	0.00%	62.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3332	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
66441-23-4	Fenoxaprop ethyl	CCOC(=O)C(C)Oc1ccc(OC2=Nc3ccc(Cl)cc3O2)cc1	0.3072	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	6.67%	53.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3072	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
67564-91-4	Fenpropimorph	CC(Cc1ccc(C(C)(C)C)cc1)CN1CC(C)OC(C)C1	0.1337	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	47.06%	23.53%	29.41%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1337	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
101-42-8	Fenuron	CN(C)C(=O)Nc1ccccc1	0.1225	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1225	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
98319-26-7	Finasteride	CC(C)(C)NC(=O)C1CCC2C3CCC4C(C)(C=CC(=O)N4)C3CCC12C	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	59.26%	11.11%	29.63%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
120068-37-3	Fipronil	NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1c1c(Cl)cc(C(F)(F)F)cc1Cl	0.3077	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3077	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
145701-23-1	Florasulam	COc1ncc(F)c2NC(S(=O)(=O)Nc3c(F)cccc3F)=Nn{+}12	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	7.14%	0.00%	92.86%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1622-62-4	Flunitrazepam	CN1C(=O)CN=C(c2ccccc2F)c2cc(N(=O)=O)ccc12	0.2164	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	 	 	In domain	69.23%	0.00%	30.77%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	 	0.2164	in vivo Liver Clastogen positive	Interaction with DNA 	Fused-Ring Nitroaromatics	Undetermined (0 <n< 10)	 	 	Out of Domain
206-44-0	Fluoranthene	c1cccc2c1c1cccc3cccc2c13	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
86-73-7	Fluorene	C1c2ccccc2-c2ccccc12	0.2078	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2078	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
54910-89-3	Fluoxetine	CNCCC(c1ccccc1)Oc1ccc(C(F)(F)F)cc1	0.1553	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	0.1553	in vivo Liver Clastogen negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	Out of Domain
69377-81-7	Fluroxypyr	Nc1c(Cl)c(F)nc(OCC(O)=O)c1Cl	0.3	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
96525-23-4	Flurtamone	CNC1=C(c2cccc(C(F)(F)F)c2)C(=O)C(c2ccccc2)O1	0.0705	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Geminal Polyhaloalkane Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.0705	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
85509-19-9	Flusilazole	C[Si](CN1C=NC=N1)(c1ccc(F)cc1)c1ccc(F)cc1	0.3943	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3943	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
13311-84-7	Flutamide	CC(C)C(=O)Nc1ccc(N(=O)=O)c(C(F)(F)F)c1	0.1657	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Geminal Polyhaloalkane Derivatives,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 52. Carboxylic acid amines	In domain	42.86%	0.00%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.1657	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
944-22-9	Fonofos	CCOP(=S)(CC)Sc1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	Out of Domain
54-31-9	Furosemide	NS(=O)(=O)c1cc(C(O)=O)c(NCC2=CC=CO2)cc1Cl	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Arenesulphonamides	 	 	 	Out of Domain
60142-96-3	Gabapentin	NCC1(CC(O)=O)CCCCC1	0.6793	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.6793	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1222-05-5	"Galaxolide (1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta(g)-2-benzopyrane)"	CC1COCc2cc3c(cc12)C(C)(C)C(C)C3(C)C	0.1336	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	57.14%	0.00%	42.86%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1336	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
58-89-9	"gamma-Hexachlorocyclohexane (gamma-HCH, Lindane)"	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	0.5329	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	0.5329	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
25812-30-0	Gemfibrozil	Cc1ccc(C)cc1OCCCC(C)(C)C(O)=O	0.229	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	69.23%	0.00%	30.77%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.229	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
446-72-0	Genistein	Oc1ccc(C2=COc3cc(O)cc(O)c3C2=O)cc1	0.2126	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds,Hydroxylated phenols"	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	In domain	10.00%	0.00%	90.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2126	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
106-24-1	Geraniol	CC(C)=CCCC(C)=CCO	0.2221	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 29. Unsaturated Compounds	In domain	9.09%	0.00%	90.91%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.2221	in vivo Liver Clastogen negative	 	 	 	Belongs to deacivated path	* 29. Unsaturated Compounds	Out of Domain
1071-83-6	Glyphosate	OC(=O)CNCP(O)(O)=O	0.25	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.25	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
23092-17-3	Halazepam	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F	0.0834	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	57.14%	0.00%	42.86%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0834	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
25637-99-4	HBCD / HBCDD (Hexabromocyclododecane)	BrC1CCC(Br)C(Br)CCC(Br)C(Br)CCC1Br	0.1068	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Haloalcohols,Halogenated Vicinal Hydrocarbons"	 	 	0.1068	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
76-44-8	Heptachlor	ClC1C=CC2C1C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	 	In domain	23.53%	0.00%	76.47%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	 	Out of Domain
*-33-2	Heptachloroepoxide	ClC1C2C(C3C1C1(Cl)C(Cl)=C(Cl)C3(Cl)C1(Cl)Cl)O2	0.8452	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Haloalkanes Containing Heteroatom,Epoxides and Aziridines"	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Haloalcohols,Halogenated Vicinal Hydrocarbons"	 	 	0.8452	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Haloalkanes Containing Heteroatom,Epoxides and Aziridines"	 	 	 	Out of Domain
3089-11-0	Hexa(methoxymethyl) melamine	COCN(COC)c1nc(N(COC)COC)nc(N(COC)COC)n1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	54.55%	0.00%	45.45%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
118-74-1	Hexachlorobenzene	Clc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl	0.475	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.475	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
608-73-1	Hexachlorocyclohexane	ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl	0.5329	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Vicinal Dihaloalkanes,alpha-Activated Haloalkanes"	 	 	0.5329	in vivo Liver Clastogen negative	 	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	 	 	 	Out of Domain
140-72-7	Hexadecylpyridinium	CCCCCCCCCCCCCCCCn{+}1(.Br{-})ccccc1	0.3522	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	83.33%	0.00%	16.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3522	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
57-09-0	Hexadecyltrimethylammonium	CCCCCCCCCCCCCCCCN{+}(C)(C)(C).Br{-}	0.2488	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2488	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
118-56-9	Homosalate	CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1	0.2025	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 20. Phenolic Derivatives;* 21. Phenolic Derivatives;25. Phenolic Derivatives	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.2025	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	 	Out of Domain
*-33-9	HpCDD (Heptachlorodibenzo-p-dioxins)	 																													
*-34-0	HpCDF (Heptachlorodibenzofurans)	 																													
*-34-1	HxCDD (Hexachlorodibenzo-p-dioxins)	 																													
*-34-2	HxCDF (Hexachlorodibenzofurans)	 																													
58-93-5	Hydrochlorothiazide	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	0.2	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
127-07-1	Hydroxycarbamide	NC(=O)NO	0.5	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"N-HydroxylAmines,Hydroxamic acid"	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5	in vivo Liver Clastogen positive	Interaction with DNA 	"N-HydroxylAmines,Hydroxamic acid"	Undetermined (0 <n< 10)	 	 	Out of Domain
15687-27-1	Ibuprofen	CC(C)Cc1ccc(C(C)C(O)=O)cc1	0.2268	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2268	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
119515-38-7	Icaridin (Bayrepel)	CCC(C)OC(=O)N1CCCCC1CCO	0.1256	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carbamates	 	 	 	In domain	56.25%	0.00%	43.75%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Carbamates	 	 	0.1256	in vivo Liver Clastogen negative	 	Carbamates	 	 	 	Out of Domain
3778-73-2	Ifosfamide	O=P1(NCCCl)N(CCCl)CCCO1	0.1002	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Haloalkanes Containing Heteroatom,Nitrogen Mustards"	Undetermined (0 <n< 10)	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Haloalkanes Containing Heteroatom,Nitrogen Mustards"	Undetermined (0 <n< 10)	 	0.1002	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Haloalkanes Containing Heteroatom,Nitrogen Mustards"	Undetermined (0 <n< 10)	 	 	In domain
35554-44-0	Imazalil	C=CCOC(CN1C=CN=C1)c1ccc(Cl)cc1Cl	0.4905	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	35.71%	7.14%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.4905	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
256-96-2	Iminostilbene	C1=Cc2ccccc2Nc2ccccc12	0.1973	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1973	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
193-39-5	"Indeno(1,2,3-c,d)pyrene"	c1cccc2c1c1ccc3ccc4cccc5cc2c1c3c45	0	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
*-35-1	Indicator (EC-6)	 																													
53-86-1	Indometacin	CC1=C(CC(O)=O)c2cc(OC)ccc2N1C(=O)c1ccc(Cl)cc1	0.3119	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3119	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
66108-95-0	Iohexol	CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	0.3057	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of domain	58.62%	0.00%	41.38%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	 	0.3057	in vivo Liver Clastogen negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of Domain
78649-41-9	Iomeprol	CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	0.2543	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of domain	61.54%	0.00%	38.46%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.2543	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
60166-93-0	Iopamidol	CC(O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I	0.1939	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of domain	57.69%	0.00%	42.31%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.1939	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
*-35-6	Iopromide	CN(CC(O)CO)C(=O)c1c(I)c(NC(=O)COC)c(I)c(C(=O)NCC(O)CO)c1I	0.1774	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of domain	59.26%	0.00%	40.74%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.1774	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
55406-53-6	IPBC (3-Iodopropynyl butylcarbamate)	CCCCNC(=O)OCC#CI	0.1984	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carbamates	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1984	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
2855-13-2	Isophorone diamine	CC1(C)CC(N)CC(C)(CN)C1	0.3159	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3159	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
34123-59-6	Isoproturon	CC(C)c1ccc(NC(=O)N(C)C)cc1	0.1123	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	0.1123	in vivo Liver Clastogen positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
*-36-0	I-TEQ (International-ToxicEquivalentQuantities) Lower-bound	 																													
*-36-1	I-TEQ (International-ToxicEquivalentQuantities) Middle-bound	 																													
*-36-2	I-TEQ (International-ToxicEquivalentQuantities) Upper-bound	 																													
65277-42-1	Ketoconazole	CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=CN=C4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	0.345	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.77%	0.00%	69.23%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.345	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
22071-15-4	Ketoprofen	CC(c1cccc(C(=O)c2ccccc2)c1)C(O)=O	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	44.44%	0.00%	55.56%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
91465-08-6	Lambda-cyhalothrin	CC1(C)C(C=C(Cl)C(F)(F)F)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1	0.2126	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	23.81%	4.76%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	0.2126	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Cyanohydrins	Undetermined (0 <n< 10)	 	 	Out of Domain
65277-51-2	Lauramidopropylbetaine	CCCCCCCCCCCC(=O)NCCCN{+}(C)(C)CC(=O)O{-}	0.3522	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3522	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
142-54-1	Lauric isopropanolamide	CCCCCCCCCCCC(=O)NCC(C)O	0.2001	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines	In domain	88.89%	0.00%	11.11%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2001	in vivo Liver Clastogen negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of Domain
120-40-1	Lauryl diethanolamide	CCCCCCCCCCCC(=O)N(CCO)CCO	0.2094	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	80.00%	0.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2094	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7439-92-1	Lead (Pb) - dissolved	[Pb]																													
7439-92-1	Lead (Pb) - total	[Pb]_[Pb]																													
01-08-64	Lenacil	O=C1C2CCCC=2NC(=O)N1C1CCCCC1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Pyrimidines and Purines	 	 	 	In domain	35.29%	0.00%	64.71%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	Pyrimidines and Purines	 	 	 	Out of Domain
58-25-3	Librium (Chlordiazepoxide)	CNC1CN(=O)=C(c2ccccc2)c2cc(Cl)ccc2N=1	0.102	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	9.09%	0.00%	90.91%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.102	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
137-58-6	Lidocain	CCN(CC)CC(=O)Nc1c(C)cccc1C	0.134	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	In domain	33.33%	8.33%	58.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	0.134	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	Out of Domain
154-21-2	Lincomycin	CCCC1CC(C(=O)NC(C(C)O)C2C(O)C(O)C(O)C(SC)O2)N(C)C1	0.3887	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	3.70%	29.63%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3887	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
330-55-2	Linuron	CN(C(=O)Nc1ccc(Cl)c(Cl)c1)OC	0.0769	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	10.00%	0.00%	90.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	 	 	0.0769	in vivo Liver Clastogen negative	 	N-Substituted Aromatic Amines	 	 	 	Out of Domain
846-49-1	Lorazepam	OC1C(=O)Nc2ccc(Cl)cc2C(c2ccccc2Cl)=N1	0.2973	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	Belongs to deacivated path	53. Carboxylic acid amines	In domain	27.27%	0.00%	72.73%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	0.2973	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
7439-95-4	Magnesium (Mg)  total	[Mg]																													
121-75-5	Malathion	CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC	0.0873	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	47.37%	5.26%	47.37%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0873	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
7439-96-5	Manganese (Mn) - total	[Mn]																													
94-74-6	MCPA	Cc1cc(Cl)ccc1OCC(O)=O	0.2831	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2831	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
93-65-2	MCPP (Mecoprop)	CC(C(O)=O)Oc1ccc(Cl)cc1C	0.3406	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	44.44%	0.00%	55.56%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3406	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
61-68-7	Mefenamic acid	Cc1cccc(Nc2ccccc2C(O)=O)c1C	0.2219	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2219	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
2032-65-7	Mercaptodimethur (Methiocarb)	Cc1cc(OC(=O)NC)cc(C)c1SC	0.249	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	0.249	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
7439-97-6	Mercury (Hg) - dissolved	[Hg]																													
7439-97-6	Mercury (Hg) - total	[Hg]_[Hg]																													
72-33-3	Mestranol	CC12CCC3C(CCc4cc(OC)ccc34)C1CCC2(O)C#C	0.2532	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2532	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
41394-05-2	Metamitrone	CC1=NN=C(c2ccccc2)C(=O)N1N	0.3906	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	0.3906	in vivo Liver Clastogen positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
50567-35-6	Metamizole	CC1=C(N(C)CS(O)(=O)=O)C(=O)N(c2ccccc2)N1C	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
67129-08-2	Metazachlor	Cc1cccc(C)c1N(CN1C=CC=N1)C(=O)CCl	0.2767	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	21.43%	0.00%	78.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	0.2767	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
*72960-62-2	Metazachlor ethane sulfonic acid (ESA)	Cc1cccc(C)c1N(CN1C=CC=N1)C(=O)CS(O)(=O)=O	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	11.76%	0.00%	88.24%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*-39-1	Metazachlor oxanilic acid (OA)	CCc1cccc(C)c1N(C(C)COC)C(=O)C(O)=O	0.213	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.213	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
657-24-9	Metformin	CN(C)C(=N)N=C(N)N	0.0753	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0753	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
29385-43-1	Methyl-1H-benzotriazole / Tolyltriazole	CN1c2ccccc2N=N1	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
51218-45-2	Metolachlor	CCc1cccc(C)c1N(C(C)COC)C(=O)CCl	0.1727	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	57.14%	0.00%	42.86%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha-Activated Haloalkanes,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.1727	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
171118-09-5	Metolachlor ESA	CCc1cccc(C)c1N(C(C)COC)C(=O)CS(O)(=O)=O	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	41.18%	0.00%	58.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
152019-73-3	Metolachlor OA	CCc1cccc(C)c1N(C(C)COC)C(=O)C(O)=O	0.213	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.213	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
37350-58-6	Metoprolol	CC(C)NCC(O)COc1ccc(CCOC)cc1	0.1712	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	78.57%	7.14%	14.29%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1712	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
21087-64-9	Metribuzine	CC(C)(C)C1C(=O)N(N)C(SC)=NN=1	0.8242	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	21.43%	0.00%	78.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	0.8242	in vivo Liver Clastogen positive	Interaction with DNA 	Hydrazine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
90-94-8	Michler's ketone	CN(C)c1ccc(C(=O)c2ccc(N(C)C)cc2)cc1	0.0406	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	70.00%	0.00%	30.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	0.0406	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
59467-64-0	Midazolam	CC1=NC=C2CN=C(c3ccccc3F)c3cc(Cl)ccc3N12	0.2031	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	15.38%	0.00%	84.62%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2031	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
7439-98-7	Molibdenum (Mo) - total	[Mo]																													
17090-79-8	Monensin	CCC1(C2C(C)CC(C3C(C)CC(C)C(O)(CO)O3)O2)CCC(C2(C)CCC3(CC(O)C(C)C(C(C)C(C(C)C(O)=O)OC)O3)O2)O1	0.3578	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	48.94%	4.26%	46.81%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3578	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
2528-16-7	Monobenzyl-phthalate	OC(=O)c1ccccc1C(=O)OCc1ccccc1	0.4296	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain	77.78%	0.00%	22.22%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4296	in vivo Liver Clastogen negative	 	Arenecarboxylic Acid Esters	 	 	 	Out of Domain
*-40-4	Monobutyltin-cation	CCCC[Sn]{+}	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
2306-33-4	Monoethyl-phthalate	CCOC(=O)c1ccccc1C(O)=O	0.4583	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain	88.89%	0.00%	11.11%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4583	in vivo Liver Clastogen negative	 	Arenecarboxylic Acid Esters	 	 	 	Out of Domain
30833-53-5	Mono-iso-butyl-phthalate	CC(C)COC(=O)c1ccccc1C(O)=O	0.4296	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenecarboxylic Acid Esters	 	 	 	In domain	90.91%	0.00%	9.09%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4296	in vivo Liver Clastogen negative	 	Arenecarboxylic Acid Esters	 	 	 	Out of Domain
83-66-9	Musk ambrette	Cc1c(N(=O)=O)cc(C(C)(C)C)c(OC)c1N(=O)=O	0.2889	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	 	 	In domain	64.29%	0.00%	35.71%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	 	0.2889	in vivo Liver Clastogen negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	 	 	Out of Domain
81-15-2	Musk xylene	Cc1c(N(=O)=O)c(C)c(N(=O)=O)c(C(C)(C)C)c1N(=O)=O	0.2086	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polynitroarenes	 	 	 	In domain	68.75%	0.00%	31.25%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Polynitroarenes,Substituted Anilines"	 	 	0.2086	in vivo Liver Clastogen negative	 	Polynitroarenes	 	 	 	Out of Domain
24280-93-1	Mycophenolic acid	CC(CCC(O)=O)=CCc1c(OC)c(C)c2COC(=O)c2c1O	0.2164	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 21. Phenolic Derivatives	In domain	38.89%	0.00%	61.11%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	0.2164	in vivo Liver Clastogen negative	 	 	 	Belongs to deacivated path	* 21. Phenolic Derivatives	Out of Domain
99-98-9	"N,N'-dimethyl-p-phenylenediamine"	CN(C)c1ccc(N)cc1	0.3179	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	In domain	80.00%	0.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Single-ring Substituted Primary Aromatic Amines	Undetermined (0 <n< 10)	 	0.3179	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	Out of Domain
1643-20-5	"N,N-dimethyldodecylamine N-oxide"	CCCCCCCCCCCCN(C)(C)=O	0.0655	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	68.75%	0.00%	31.25%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0655	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3984-14-3	"N,N-Dimethylsulfamid"	CN(C)S(N)(=O)=O	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
91-20-3	Naphthalene	c1cccc2ccccc12	0.1003	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1003	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
22204-53-1	Naproxen	CC(c1ccc2cc(OC)ccc2c1)C(O)=O	0.4608	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.4608	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3622-84-2	n-Butylbenzenesulfonamide	CCCCNS(=O)(=O)c1ccccc1	0.4132	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	In domain	55.56%	0.00%	44.44%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	0.4132	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	Out of Domain
1515-72-6	n-Butylphthalimide	CCCCN1C(=O)c2ccccc2C1=O	0.2309	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.00%	0.00%	70.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain	 	 	0.2309	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
62-75-9	NDMA (N-Nitrosodimethylaromatic amines)	CN(C)N=O	0	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	"N-Nitroso Compounds,N-nitrosoamine Derivatives"	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-Nitroso Compounds	"High, >= 60% (n>=10)"	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	N-Nitroso Compounds	"High, >= 60% (n>=10)"	 	 	In domain
7440-02-0	Nickel (Ni) - dissolved	[Ni]																													
7440-02-0	Nickel (Ni) - total	[Ni]_[Ni]																													
101-72-4	N-isopropyl-N-phenyl-p-phenylenediamine	CC(C)Nc1ccc(Nc2ccccc2)cc1	0.1167	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	28.57%	14.29%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	0.1167	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
7697-37-2	Nitrates (NO3-N)	O=N{+}(=O)O{-}																													
14797-65-0	Nitrites (NO2-N)	O=N=O																													
17778-88-0	Nitrogen (N)  total	N#N																													
59-89-2	N-Nitrosomorpholine	O=NN1CCOCC1	0	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Nitroso Compounds	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-Nitroso Compounds	"High, >= 60% (n>=10)"	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	N-Nitroso Compounds	"High, >= 60% (n>=10)"	 	 	In domain
3115-49-9	Nonylphenol monocarboxylates (NP1ECs)	CCCCCCCCCc1ccc(OCC(O)=O)cc1	0.1073	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	86.67%	0.00%	13.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.1073	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
84852-15-3	Nonylphenols	CC(C)CCCCCCc1ccc(O)cc1	0.3057	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;* 21. Phenolic Derivatives;* 26. Phenolic Derivatives	In domain	90.91%	0.00%	9.09%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	0.3057	in vivo Liver Clastogen negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;* 21. Phenolic Derivatives;* 26. Phenolic Derivatives	Out of Domain
68-22-4	Norethindrone	CC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C	0.2322	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	77.27%	0.00%	22.73%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.2322	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	Out of Domain
35189-28-7	Norgestimate / Ethynil estradiol	CCC12CCC3C(CCC4=CC(=NO)CCC34)C1CCC2(C#C)OC(C)=O	0.1379	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Specific Imine and Thione Derivatives	Undetermined (0 <n< 10)	 	 	In domain	55.56%	3.70%	40.74%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Specific Acetate Esters	 	 	0.1379	in vivo Liver Clastogen positive	Interaction with DNA 	Specific Imine and Thione Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
90-30-2	N-phenyl-1-naphthylamine	c1ccccc1Nc1cccc2ccccc12	0.3333	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	0.3333	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	N-Substituted Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
139-13-9	NTA (Nitrilotriacetic acid)	OC(=O)CN(CC(O)=O)CC(O)=O	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	46.15%	7.69%	46.15%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
53-19-0	"o,p-DDD"	ClC(Cl)C(c1ccccc1Cl)c1ccc(Cl)cc1	0.1432	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1432	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
3424-82-6	"o,p-DDE"	Clc1ccccc1C(=C(Cl)Cl)c1ccc(Cl)cc1	0.4172	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4172	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
789-02-6	"o,p-DDT"	Clc1ccccc1C(c1ccc(Cl)cc1)C(Cl)(Cl)Cl	0.2304	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	55.56%	0.00%	44.44%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2304	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*-43-4	OCDD (Octachlorodibenzo-p-dioxins)	 																													
*-43-5	OCDF (Octachlorodibenzofurans)	 																													
6197-30-4	Octocrylene	CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1	0.2599	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	41.18%	0.00%	58.82%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	0.2599	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	Out of Domain
1806-26-4	Octylphenol	CCCCCCCCc1ccc(O)cc1	0.3208	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;* 26. Phenolic Derivatives	In domain	90.00%	0.00%	10.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3208	in vivo Liver Clastogen negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives;* 26. Phenolic Derivatives	Out of Domain
119-90-4	o-Dianisidine	COc1cc(-c2ccc(N)c(OC)c2)ccc1N	0.2848	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"p-Aminobiphenyl Analogs,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	In domain	75.00%	0.00%	25.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	p-Aminobiphenyl Analogs	Undetermined (0 <n< 10)	 	0.2848	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"p-Aminobiphenyl Analogs,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	Out of Domain
82419-36-1	Ofloxacin	CC1COc2c(N3CCN(C)CC3)c(F)cc3c2N1C=C(C(O)=O)C3=O	0.3341	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.3341	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinolone Derivatives,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
26530-20-1	OIT (2-Octyl-4-isothiazolin-3-one)	CCCCCCCCN1C(=O)C=CS1	0.1872	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1872	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
73590-58-6	Omeprazole	Cc1cnc(CS(=O)C2Nc3ccc(OC)cc3N=2)c(C)c1OC	0.152	in vivo Liver Clastogen positive	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.152	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	In domain
54464-57-2	OTNE (ISO E Super)	CC1CC2CCCC(C)(C)C=2CC1(C)C(C)=O	0.1093	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	52.94%	0.00%	47.06%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.1093	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
604-75-1	Oxazepam	OC1C(=O)Nc2ccc(Cl)cc2C(c2ccccc2)=N1	0.2209	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	0.2209	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
72-54-8	"p,p-DDD"	ClC(Cl)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1	0.0956	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0956	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
72-55-9	"p,p-DDE"	Clc1ccc(C(=C(Cl)Cl)c2ccc(Cl)cc2)cc1	0.4809	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4809	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
50-29-3	"p,p-DDT"	Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1	0.0908	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	77.78%	0.00%	22.22%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0908	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
140-66-9	para-tert-Octylphenol	CC(C)(C)CC(C)(C)c1ccc(O)cc1	0.1871	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 21. Phenolic Derivatives	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1871	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
298-00-0	Parathion-methyl	COP(=S)(OC)Oc1ccc(N(=O)=O)cc1	0.3478	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.3478	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
61869-08-7	Paroxetine	Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1	0.2735	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	35.71%	0.00%	64.29%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2735	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
37680-73-2	"PCB 101 (2,2',4,5,5'-Pentachlorobiphenyl)"	Clc1ccc(Cl)cc1-c1cc(Cl)c(Cl)cc1Cl	0.6776	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6776	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
32598-14-4	"PCB 105 (2,3,3',4,4'-Pentachlorobiphenyl)"	Clc1ccc(-c2ccc(Cl)c(Cl)c2Cl)cc1Cl	0.5809	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5809	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
74472-37-0	"PCB 114 (1,1'-Biphenyl, 2,3,4,4',5-pentachloro-)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2Cl)cc1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
31508-00-6	"PCB 118 (2,3'4,4',5-Pentachlorobiphenyl)"	Clc1ccc(-c2cc(Cl)c(Cl)cc2Cl)cc1Cl	0.8676	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.8676	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
65510-44-3	"PCB 123 (1,1'-Biphenyl, 2',3,4,4',5-pentachloro-)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2)c(Cl)c1	0.5181	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5181	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57465-28-8	"PCB 126 (3,3',4,4',5-Pentachlorobiphenyl)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2)cc1Cl	0.556	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.556	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
35065-28-2	"PCB 138 (2,2',3,4,4',5-Hexachlorobiphenyl)"	Clc1ccc(-c2cc(Cl)c(Cl)cc2Cl)c(Cl)c1Cl	0.7419	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.7419	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
35065-27-1	"PCB 153 (2,2'4,4',5,5'-Hexachlorobiphenyl)"	Clc1cc(Cl)c(Cl)cc1-c1cc(Cl)c(Cl)cc1Cl	0.7955	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.7955	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
38380-08-4	"PCB 156 (2,3,3,4,4,5-Hexachlorbiphenyl)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2Cl)cc1Cl	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	12.50%	0.00%	87.50%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
69782-90-7	"PCB 157 (2,3,3,4,4,5-Hexachlorbiphenyl)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2)c(Cl)c1Cl	0.5625	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5625	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
52663-72-6	"PCB 167 (2,3,4,4,5,5-Hexachlorbiphenyl)"	Clc1cc(-c2cc(Cl)c(Cl)cc2Cl)cc(Cl)c1Cl	0.6548	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6548	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
32774-16-6	"PCB 169 (3,3'4,4',5,5'-Hexachlorobiphenyl)"	Clc1cc(-c2cc(Cl)c(Cl)c(Cl)c2)cc(Cl)c1Cl	0.5307	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5307	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
35065-29-3	"PCB 180 (2,2',3,4,4',5,5'-Heptachlorobiphenyl)"	Clc1cc(Cl)c(Cl)cc1-c1cc(Cl)c(Cl)c(Cl)c1Cl	0.8594	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.8594	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
39635-31-9	"PCB 189 (2,3,3,4,4,5,5-Heptachlorbiphenyl)"	Clc1cc(-c2cc(Cl)c(Cl)c(Cl)c2Cl)cc(Cl)c1Cl	0.7059	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.7059	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7012-37-5	"PCB 28 (2,4,4'-Trichlorobiphenyl)"	Clc1ccc(-c2ccc(Cl)cc2Cl)cc1	0.4893	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4893	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
35693-99-3	"PCB 52 (2,2',5,5'-Tetrachlorobiphenyl)"	Clc1ccc(Cl)cc1-c1cc(Cl)ccc1Cl	0.3312	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3312	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
32598-13-3	"PCB 77 (3,3',4,4'-Tetrachlorobiphenyl)"	Clc1ccc(-c2ccc(Cl)c(Cl)c2)cc1Cl	0.5792	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5792	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
70362-50-4	"PCB 81 (1,1'-Biphenyl, 3,4,4',5-tetrachloro-)"	Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2)cc1	0.5004	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5004	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
59-50-7	p-Chlorocresol	Cc1cc(O)ccc1Cl	0.4369	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	21. Phenolic Derivatives	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.4369	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	21. Phenolic Derivatives	Out of Domain
*-46-9	PeCDD (Pentachlorodibenzo-p-dioxins)	 																													
*-47-0	PeCDF (Pentachlorodibenzofurans)	 																													
40487-42-1	Pendimethalin	CCC(CC)Nc1c(N(=O)=O)cc(C)c(C)c1N(=O)=O	0.1723	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Polynitroarenes,N-Substituted Aromatic Amines"	 	 	 	In domain	53.33%	0.00%	46.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Polynitroarenes,N-Substituted Aromatic Amines"	 	 	0.1723	in vivo Liver Clastogen negative	 	"Nitroaniline Derivatives,Polynitroarenes,N-Substituted Aromatic Amines"	 	 	 	Out of Domain
61-33-6	Penicillin G	CC1(C)C(C(O)=O)N2C(C(NC(=O)Cc3ccccc3)C2=O)S1	0.8095	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.8095	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
608-93-5	Pentachlorobenzene	Clc1cc(Cl)c(Cl)c(Cl)c1Cl	0.6142	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.6142	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
76-74-4	Pentobarbital	CCCC(C)C1(CC)C(=O)NC(O)=NC1=O	0.1246	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	31.25%	6.25%	62.50%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Pyrimidines and Purines	 	 	0.1246	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
06-05-93	Pentoxifyline	CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O	0.0491	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Pyrimidines and Purines	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0491	in vivo Liver Clastogen negative	 	Pyrimidines and Purines	 	 	 	Out of Domain
376-06-7	Perfluorotetradecanoic acid	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of domain	4.65%	0.00%	95.35%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
52645-53-1	Permethrin (mix of isomers)	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1	0.1953	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Haloalkenes with Electron-Withdrawing Groups 	 	 	 	In domain	25.00%	6.25%	68.75%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Haloalkenes with Electron-Withdrawing Groups 	 	 	0.1953	in vivo Liver Clastogen negative	 	Haloalkenes with Electron-Withdrawing Groups 	 	 	 	Out of Domain
198-55-0	Perylene	c1ccc2cccc3c2c1c1cccc2cccc3c12	0	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	0	in vivo Liver Clastogen positive	Interaction with DNA 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
106700-29-2	Pethoxamid	CCOCCN(C(=O)CCl)C(=C(C)C)c1ccccc1	0.1871	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	0.1871	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
375-22-4	PFBA (Perfluorobutanoic acid)	OC(=O)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	15.38%	0.00%	84.62%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
45187-15-3	PFBS (Perfluorobutanesulfonate)	OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
335-76-2	PFDA (Perfluorodecanoate)	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	6.45%	0.00%	93.55%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
375-85-9	PFHpA (Perfluoroheptanoate)	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	9.09%	0.00%	90.91%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
307-24-4	PFHxA (Perfluorohexanoate)	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	10.53%	0.00%	89.47%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
375-95-1	PFNA (Perfluorononanoate)	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	7.14%	0.00%	92.86%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
335-67-1	PFOA (Perfluorooctanoate)	OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	8.00%	0.00%	92.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
1763-23-1	PFOS (Perfluorooctansulfonate)	OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
*-48-8	pH	 																													
15323-35-0	Phantolide	CC1C(C)(C)c2cc(C)c(C(C)=O)cc2C1(C)C	0.1543	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	53.85%	0.00%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1543	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
62-44-2	Phenacetin	CCOc1ccc(NC(C)=O)cc1	0.1893	in vivo Liver Clastogen negative	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	43. N-Arylacetamides;44. N-Arylacetamides	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.1893	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	Belongs to deacivated path	 	In domain
85-01-8	Phenanthrene	c1cccc2ccc3ccccc3c12	0.1221	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1221	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
60-80-0	Phenazone	CC1=CC(=O)N(c2ccccc2)N1C	0.2693	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.2693	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
122-14-5	Phenitrothion	Cc1cc(OP(=S)(OC)OC)ccc1N(=O)=O	0.3719	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Alkylphosphates, Alkylthiophosphates and Alkylphosphonates,Substituted Anilines"	Undetermined (0 <n< 10)	 	0.3719	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
27503-81-7	Phenylbenzimidazole sulfonic acid	OS(=O)(=O)c1ccc2c(c1)NC(c1ccccc1)=N2	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
732-11-6	Phosmet	COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O	0.0478	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	0.0478	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
137641-05-5	Picolinafen	O=C(c1cccc(Oc2cccc(C(F)(F)F)c2)n1)Nc1ccc(F)cc1	0.1636	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Geminal Polyhaloalkane Derivatives,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 53. Carboxylic acid amines;53. Carboxylic acid amines	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.1636	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	 	Out of Domain
13523-86-9	Pindolol	CC(C)NCC(O)COc1cccc2c1C=CN2	0.1193	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	46.15%	7.69%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1193	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
66258-76-2	Piperacillin	CCN1CCN(C(=O)NC(c2ccccc2)C(=O)NC2C3N(C(C(O)=O)C(C)(C)S3)C2=O)C(=O)C1=O	0.5138	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	29.03%	0.00%	70.97%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Carbamates	 	 	0.5138	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
51-03-6	Piperonyl butoxide	CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2	0.0935	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.68%	0.00%	26.32%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.0935	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
23103-98-2	Pirimicarb	Cc1c(C)c(OC(=O)N(C)C)nc(N(C)C)n1	0.1098	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	0.1098	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
29232-93-7	Pirimiphos-methyl	CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1	0.2068	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.2068	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
*-50-2	p-Nitrophenol	Oc1ccc(N(=O)=O)cc1	0.3289	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids"	 	Belongs to deacivated path	26. Phenolic Derivatives	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	0.3289	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Single-ring Substituted Primary Aromatic Amines,Substituted Anilines"	Undetermined (0 <n< 10)	 	 	Out of Domain
07-09-40	Potassium (K)  total	K																													
81093-37-0	Pravastatin	CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(O)=O)C12	0.1962	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	63.33%	3.33%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.1962	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
2955-38-6	Prazepam	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1	0.0834	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	61.54%	0.00%	38.46%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0834	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
50-24-8	Prednisolone	CC12CC(O)C3C(CCC4=CC(=O)C=CC34C)C1CCC2(O)C(=O)CO	0.4309	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	29. Unsaturated Compounds;34. Unsaturated Compounds	In domain	65.38%	0.00%	34.62%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.4309	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
125-33-7	Primidone	CCC1(c2ccccc2)C(=O)NCNC1=O	0.2438	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 52. Carboxylic acid amines	In domain	45.45%	9.09%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	0.2438	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrimidines and Purines	Undetermined (0 <n< 10)	 	 	Out of Domain
67747-09-5	Prochloraz	CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)N1C=CN=C1	0.1333	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1333	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57-83-0	Progesterone	CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	0.2114	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.2114	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain
7287-19-6	Prometryne	CC(C)Nc1nc(NC(C)C)nc(SC)n1	0.1317	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	36.36%	27.27%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1317	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
525-66-6	Propanolol	CC(C)NCC(O)COc1cccc2ccccc12	0.2569	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	70.00%	10.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.2569	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
60207-90-1	Propiconazole	CCCC1COC(CN2C=NC=N2)(c2ccc(Cl)cc2Cl)O1	0.4134	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	35.29%	0.00%	64.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.4134	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
145026-81-9	Propoxycarbazone	CCCOC1=NN(C(=O)NS(=O)(=O)c2ccccc2C(=O)OC)C(=O)N1C	0.1491	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	In domain	27.27%	0.00%	72.73%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	0.1491	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	Out of Domain
479-92-5	Propylphenazone / Isopropylphenazone	CC(C)C1=C(C)N(C)N(c2ccccc2)C1=O	0.2194	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.2194	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
52888-80-9	Prosulfocarb	CCCN(CCC)C(=O)SCc1ccccc1	0.093	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	41.67%	0.00%	58.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Thiols	 	 	0.093	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
120983-64-4	Prothioconazole-desthio	OC(Cc1ccccc1Cl)(CN1C=NC=N1)C1(Cl)CC1	0.3457	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3457	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
70-55-3	p-Toluenesulfonamide	Cc1ccc(S(N)(=O)=O)cc1	0.4607	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Arenesulphonamides	 	 	0.4607	in vivo Liver Clastogen negative	 	Arenesulphonamides	 	 	 	Out of Domain
13457-18-6	Pyrazophos	CCOC(=O)c1cn{+}2c(C=C(OP(=S)(OCC)OCC)N2)nc1C	0.252	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	31.58%	0.00%	68.42%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.252	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
129-00-0	Pyrene	c1ccc2ccc3cccc4ccc1c2c34	0	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Epoxides and Aziridines,Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives"	 	 	0	in vivo Liver Clastogen negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	Out of Domain
1121-31-9	Pyrithione	O=n1ccccc1S	0.8571	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Thiols	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Thiols	 	 	0.8571	in vivo Liver Clastogen negative	 	Thiols	 	 	 	Out of Domain
124495-18-7	Quinoxyfen	Fc1ccc(Oc2ccnc3cc(Cl)cc(Cl)c23)cc1	0.5481	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Quinoline Derivatives	 	Belongs to deacivated path	42. Haloquinolines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5481	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	42. Haloquinolines	Out of Domain
66357-35-5	Ranitidine	CNC(=CN(=O)=O)NCCSCC1=CC=C(CN(C)C)O1	0.0636	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Conjugated Nitro Compounds	Undetermined (0 <n< 10)	 	 	In domain	9.52%	4.76%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Conjugated Nitro Compounds	Undetermined (0 <n< 10)	 	0.0636	in vivo Liver Clastogen positive	Interaction with DNA 	Conjugated Nitro Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
483-65-8	Retene	CC(C)c1ccc2c(c1)ccc1c2cccc1C	0.1366	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	40.00%	0.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1366	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
80214-83-1	Roxithromycin	CCC1C(C)(O)C(O)C(C)C(=NOCOCCOC)C(C)CC(C)(O)C(OC2C(O)C(N(C)C)CC(C)O2)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(=O)O1	0.1751	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	Out of domain	63.79%	1.72%	34.48%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1751	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
81-07-2	Saccharin	O=C1c2ccccc2S(=O)(=O)N1	0.2894	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Arenesulphonamides"	 	Belongs to deacivated path	* 52. Carboxylic acid amines;53. Carboxylic acid amines	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	Belongs to deacivated path	0.2894	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	Belongs to deacivated path	53. Carboxylic acid amines	Out of Domain
35763-26-9	Salbutamol	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	41.67%	0.00%	58.33%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
69-72-7	Salicylic acid	Oc1ccccc1C(O)=O	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
122-34-9	Simazine	CCNc1nc(NCC)nc(Cl)n1	0.1979	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	75.00%	0.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1979	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1014-70-6	Simetryn	CCNc1nc(NCC)nc(SC)n1	0.1707	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.22%	44.44%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1707	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
79902-63-9	Simvastatin	CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C12	0.0797	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	63.33%	3.33%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.0797	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7440-23-5	Sodium (Na)  total	[Na]																													
3930-20-9	Sotalol	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	0.1712	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	76.92%	7.69%	15.38%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1712	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
118134-30-8	Spiroxamine	CCCN(CC)CC1COC2(CCC(C(C)(C)C)CC2)O1	0.1429	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	57.14%	9.52%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1429	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*-53-4	 	 																													
56038-13-2	Sucralose	OCC1C(Cl)C(O)C(O)C(OC2(CCl)C(O)C(O)C(CCl)O2)O1	0.6691	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Haloalkanes Containing Heteroatom,Haloalcohols"	 	 	 	In domain	52.17%	0.00%	47.83%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Haloalkanes Containing Heteroatom,Haloalcohols"	 	 	0.6691	in vivo Liver Clastogen negative	 	"Haloalkanes Containing Heteroatom,Haloalcohols"	 	 	 	Out of Domain
99105-77-8	Sulcotrione	CS(=O)(=O)c1ccc(C(=O)C2C(=O)CCCC2=O)c(Cl)c1	0.3467	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	31.25%	0.00%	68.75%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3467	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
57-68-1	Sulfadimidin / Sulfamethazin	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	0.3012	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Arenesulphonamides"	Undetermined (0 <n< 10)	 	0.3012	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines	Out of Domain
723-46-6	Sulfamethoxazole	CC1=CC(NS(=O)(=O)c2ccc(N)cc2)=NO1	0.353	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	Belongs to deacivated path	2. Single Ring Aromatic Amines	In domain	8.33%	0.00%	91.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Arenesulphonamides"	Undetermined (0 <n< 10)	 	0.353	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Arenesulphonamides"	Undetermined (0 <n< 10)	 	 	Out of Domain
144-83-2	Sulfapyridine	Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	0.402	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	In domain	42.86%	0.00%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"N-HydroxylAmines,Arenesulphonamides"	Undetermined (0 <n< 10)	 	0.402	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	Out of Domain
126-33-0	Sulfolane	O=S1(=O)CCCC1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.57%	0.00%	71.43%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
14808-79-8	Sulphates (SO4--)	OS(O)(=O)=O																													
*-54-2	Sum of TDC2PP and TDCPP	 																													
*-54-3	Suspended solids	 																													
68937-41-7	T2IPPP (Tris(2-isopropylphenyl phosphate)	CC(C)c1ccc(OP(=O)(Oc2ccc(C(C)C)cc2)Oc2ccc(C(C)C)cc2)cc1	0.1991	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	47.06%	0.00%	52.94%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1991	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
9006-37-5	"T35DMPP (Tris(3,5-dimethylphenyl phosphate)"	Cc1cc(C)cc(OP(Oc2cc(C)cc(C)c2)Oc2cc(C)cc(C)c2)c1	0.2284	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2284	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
79-94-7	TBBPA (Tetrabromobisphenol A)	CC(C)(c1cc(Br)c(O)c(Br)c1)c1cc(Br)c(O)c(Br)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
78-51-3	TBEP (Tris(2-butoxyethyl)phosphate)	CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC	0.1342	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	88.46%	0.00%	11.54%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.1342	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	Out of Domain
126-73-8	TBP (Trybutyl phosphate)	CCCCOP(=O)(OCCCC)OCCCC	0.1764	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	82.35%	0.00%	17.65%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.1764	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	Out of Domain
*-54-9	TCDD (Tetrachlorodibenzo-p-dioxins)	 																													
*-55-0	TCDF (Tetrachlorodibenzofurans)	 																													
115-96-8	TCEP (Tris(2-chloroethyl)phosphate)	O=P(OCCCl)(OCCCl)OCCCl	0.1461	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates,Haloalkanes Containing Heteroatom"	 	 	 	In domain	78.57%	0.00%	21.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	0.1461	in vivo Liver Clastogen positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	 	Out of Domain
6515-38-4	"TCP (3,5,6-Trichloro-2-pyridinol)"	Oc1c(Cl)cc(Cl)c(Cl)n1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
13674-84-5	TCPP (Tris(1-chloro-2-propyl)phosphate)	CC(CCl)OP(=O)(OC(C)CCl)OC(C)CCl	0.1964	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates,Haloalkanes Containing Heteroatom"	 	 	 	In domain	47.06%	0.00%	52.94%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	0.1964	in vivo Liver Clastogen positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	 	Out of Domain
13674-87-8	"TDC2PP (Tris(1,3-dichloro-2-propyl)phosphate)"	O=P(OC(CCl)CCl)(OC(CCl)CCl)OC(CCl)CCl	0.2242	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates,Haloalkanes Containing Heteroatom"	 	 	 	In domain	40.00%	0.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	0.2242	in vivo Liver Clastogen positive	Interaction with DNA 	Haloalcohols	Undetermined (0 <n< 10)	 	 	Out of Domain
126-72-7	"TDCPP (Tris(2,3-dibromopropyl)phosphate)"	O=P(OCC(Br)CBr)(OCC(Br)CBr)OCC(Br)CBr	0.4162	in vivo Liver Clastogen positive	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	Undetermined (0 <n< 10)	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	Undetermined (0 <n< 10)	 	0.4162	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Vicinal Dihaloalkanes,Halogenated Vicinal Hydrocarbons"	Undetermined (0 <n< 10)	 	 	In domain
107534-96-3	Tebuconazol	CC(C)(C)C(O)(CCc1ccc(Cl)cc1)CN1C=NC=N1	0.2831	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2831	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
78-42-2	TEHP (Tris(2-Ethylhexyl) phosphate)	CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC	0.221	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.221	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain
846-50-4	Temazepam	CN1c2ccc(Cl)cc2C(c2ccccc2)=NC(O)C1=O	0.1378	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	72.73%	0.00%	27.27%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1378	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
3383-96-8	Temephos	COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1	0.1033	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.1033	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
13071-79-9	Terbufos	CCOP(=S)(OCC)SCSC(C)(C)C	0.0871	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	0.0871	in vivo Liver Clastogen positive	Interaction with DNA 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	Undetermined (0 <n< 10)	 	 	Out of Domain
23031-25-6	Terbutaline	CC(C)(C)NCC(O)c1cc(O)cc(O)c1	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Hydroxylated phenols	 	 	 	In domain	36.36%	0.00%	63.64%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	Hydroxylated phenols	 	 	 	Out of Domain
886-50-0	Terbutryn	CCNc1nc(NC(C)(C)C)nc(SC)n1	0.2809	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	18.18%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2809	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
5915-41-3	Terbutylazine	CCNc1nc(NC(C)(C)C)nc(Cl)n1	0.3281	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	40.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3281	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
30125-63-4	Terbutylazine-desethyl / Desethylterbutylazine	CC(C)(C)Nc1nc(N)nc(Cl)n1_R	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	37.50%	12.50%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
58-22-0	Testosterone	CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2O	0.2941	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	95.24%	4.76%	0.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2941	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
1461-25-2	Tetrabutyltin	CCCC[Sn](CCCC)(CCCC)CCCC	0.2619	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	70.59%	0.00%	29.41%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2619	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1154-59-2	Tetrachlorosalicylanilide	Oc1c(Cl)cc(Cl)cc1C(=O)Nc1ccc(Cl)c(Cl)c1	0.5177	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives;53. Carboxylic acid amines	In domain	30.00%	0.00%	70.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5177	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives;53. Carboxylic acid amines	Out of Domain
148-79-8	Thiabendazole	c1cccc2c1NC(C1=CSC=N1)=N2	0.3704	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.3704	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
111988-49-9	Thiacloprid	N#CN=C1N(Cc2ccc(Cl)nc2)CCS1	0.1674	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1674	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
89-83-8	Thymol	CC(C)c1ccc(C)cc1O	0.1987	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	21. Phenolic Derivatives;26. Phenolic Derivatives	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1987	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
126-71-6	TIBP (Tryisobutyl phosphate)	CC(C)COP(=O)(OCC(C)C)OCC(C)C	0.1734	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.1734	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain
126-86-3	"TMDD (2,4,7, 9-Tetramethyl-5-decyne-4,7-diol)"	CC(C)CC(C)(O)C#CC(C)(O)CC(C)C	0.346	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	75.00%	0.00%	25.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.346	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
126-54-5	"TOSU (2,4,8,10-Tetraoxaspiro[5.5]undecane)"	C1C2(COCO1)COCOC2	0	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	54.55%	36.36%	9.09%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*-57-4	Total Chlorinated PCBs (group PCB)	 																													
*-57-5	Total Hepta-CBs (group PCB)	 																													
*-57-6	Total Hexa-CBs (group PCB)	 																													
*-57-7	Total Indicator PCBs	 																													
*-57-8	Total PCDD/Furans	 																													
*-57-9	Total PCDDs	 																													
*-58-0	Total PCDFs	 																													
*-58-1	Total Penta-CBs (group PCB)	 																													
7723-14-0	Total phosphorus (TP)	P																													
*-58-3	Total Tetra-CBs (group PCB)	 																													
*-58-4	Total Tri-CBs (group PCB)	 																													
115-86-6	TPP (Tryphenyl phosphate)	O=P(Oc1ccccc1)(Oc1ccccc1)Oc1ccccc1	0.139	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.139	in vivo Liver Clastogen positive	Interaction with DNA  &Interactions with topoisomerases / proteins	"Quinones and Trihydroxybenzenes,alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
513-08-6	TPrP (Tri-n-propylphosphate)	CCCOP(=O)(OCCC)OCCC	0.1764	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	78.57%	0.00%	21.43%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.1764	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	Out of Domain
27203-92-5	Tramadol	CN(C)CC1CCCCC1(O)c1cccc(OC)c1	0.2385	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	57.14%	14.29%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2385	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
36643-28-4	Tributyltin-cation	CCCC[Sn]{+}(CCCC)CCCC	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	69.23%	0.00%	30.77%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
101-20-2	Triclocarban	O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3380-34-5	Triclosan	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	0.5491	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	26. Phenolic Derivatives	In domain	42.86%	0.00%	57.14%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5491	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	Belongs to deacivated path	 	Out of Domain
01-01-40	Triclosan-methyl	COc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	0.517	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	62.50%	0.00%	37.50%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.517	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
77-93-0	Triethyl citrate	CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC	0.1315	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	84.21%	0.00%	15.79%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1315	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
112-49-2	Triethylenglycol dimethylether (Triglyme)	COCCOCCOCCOC	0.0414	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0414	in vivo Liver Clastogen negative	 	 	 	 	 	In domain
141517-21-7	Trifloxystrobin	CC(c1cccc(C(F)(F)F)c1)=NOCc1ccccc1C(C(=O)OC)=NOC	0.0681	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	0.0681	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	Out of Domain
1582-09-8	Trifluralin	CCCN(CCC)c1c(N(=O)=O)cc(C(F)(F)F)cc1N(=O)=O	0.2497	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Polynitroarenes,Geminal Polyhaloalkane Derivatives"	 	 	 	In domain	55.56%	0.00%	44.44%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Geminal Polyhaloalkane Derivatives,Substituted Anilines"	 	 	0.2497	in vivo Liver Clastogen negative	 	"Nitroaniline Derivatives,Polynitroarenes,Geminal Polyhaloalkane Derivatives"	 	 	 	Out of Domain
738-70-5	Trimethoprim	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	0.2019	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	27.27%	0.00%	72.73%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2019	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
2083-68-3	Trimethyloctylammonium	CCCCCCCCN{+}(C)(C)(C).Br{-}	0.2488	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	53.85%	0.00%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2488	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
217-59-4	Triphenylene	c1cccc2c1c1ccccc1c1ccccc21	0.1081	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Polycyclic Aromatic Hydrocarbon and Naphthalenediimide Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	0.1081	in vivo Liver Clastogen positive	Interaction with DNA 	Epoxides and Aziridines	Undetermined (0 <n< 10)	 	 	Out of Domain
791-28-6	Triphenylphosphine oxide	O=P(c1ccccc1)(c1ccccc1)c1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
668-34-8	Triphenyltin-cation	c1ccccc1[Sn]{+}(c1ccccc1)c1ccccc1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
563-04-2	Tris-m-cresylphosphate	Cc1cccc(OP(=O)(Oc2cccc(C)c2)Oc2cccc(C)c2)c1	0.2032	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	45.45%	0.00%	54.55%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2032	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
78-30-8	Tris-o-cresylphosphate	Cc1ccccc1OP(=O)(Oc1ccccc1C)Oc1ccccc1C	0.1596	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	45.45%	0.00%	54.55%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1596	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
78-32-0	Tris-p-cresylphosphate	Cc1ccc(OP(=O)(Oc2ccc(C)cc2)Oc2ccc(C)cc2)cc1	0.1804	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1804	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
1330-78-5	TTP (Trytolyl phosphate - sum of isomers)	Cc1ccc(OP(=O)(Oc2ccc(C)cc2)Oc2ccc(C)cc2)cc1	0.1804	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1804	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
93413-69-5	Venlafaxine	CN(C)CC(c1ccc(OC)cc1)C1(O)CCCCC1	0.1817	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	13.33%	13.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1817	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
52-53-9	Verapamil	CC(C)C(CCCN(C)CCc1ccc(OC)c(OC)c1)(C#N)c1ccc(OC)c(OC)c1	0.0731	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	65.22%	0.00%	34.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0731	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
81-81-2	Warfarin	CC(=O)CC(c1ccccc1)C1=C(O)Oc2ccccc2C1=O	0.1614	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	30.77%	0.00%	69.23%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1614	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*-60-8	Water temperature	 																													
7440-66-6	Zinc (Zn) - dissolved	[Zn]																													
7440-66-6	Zinc (Zn) - total	[Zn]_[Zn]																													
83-46-5	-Sitosterol	CCC(CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C	0.3117	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.3117	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*-61-2	Quaternium 15 (free base)	ClC=CCN{+}12(.Cl{-})CN3CN(C1)CN(C2)C3	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hexahydrotriazine Derivatives	Undetermined (0 <n< 10)	 	 	Out of domain	0.00%	20.00%	80.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hexahydrotriazine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
10127-27-2	Acid orange 74	CC1C{-}2(C(=O)N(c3ccccc3)N=1)N=Nc1cc(N(=O)=O)cc3c1O{-}.[Cr]{3+}.2.O{-}S3(=O)=O_O{-}.[Na]{+}	0.2112	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Can't calculate	10.00%	0.00%	90.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	0.2112	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Pyrazolone and Pyrazolidine Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
113-45-1	Methylphenidate	COC(=O)C(C1CCCCN1)c1ccccc1	0.0854	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	58.33%	8.33%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0854	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1088-11-5	Nordiazepam	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1	0.0745	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carboxylic Acid Amides	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.0745	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
66753-07-9	Terbutylazine-2-hydroxy	CCNc1nc(NC(C)(C)C)nc(O)n1	0.3226	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	20.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3226	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
6104-71-8	N-Desmethylclozapine	Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2	0.1978	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	8.33%	0.00%	91.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	0.1978	in vivo Liver Clastogen positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
66753-06-8	Terbutylazine-desethyl-2-hydroxy	CC(C)(C)Nc1nc(N)nc(O)n1	N/A	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	37.50%	0.00%	62.50%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
16590-41-3	Naltrexone	Oc1ccc2CC3C4(O)CCC(=O)C5C4(CCN3CC3CC3)c2c1O5	0.6019	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	25.00%	15.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.6019	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
42200-33-9	Nadolol	CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12	0.497	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	82.35%	0.00%	17.65%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.497	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
135410-20-7	Acetamiprid	CC(=N\C#N)N(C)Cc1ccc(Cl)nc1	0.0831	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0831	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
57-27-2	Morphine	CN1CCC{P-}23C{P-}4C=CC{P+}(O)C{P+}2Oc2c3c(CC{P-}14)ccc2O	0.409	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	31.25%	0.00%	68.75%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.409	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
84057-84-1	Lamotrigine	Nc1c(-c2cccc(Cl)c2Cl)nnc(N)n1	0.525	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.525	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
56392-14-4	Metroprolol acid	CC(C)NCC(O)COc1ccc(CC(O)=O)cc1	0.3072	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	64.29%	7.14%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3072	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
72-69-5	Nortriptyline	CNCCC=C1c2ccccc2CCc2ccccc12	0.1737	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1737	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
69610-10-2	Methylendioxymethamphetamine (MDMA)	CC(Cc1ccc2c(c1)OCO2)NC	0.2191	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	55.56%	0.00%	44.44%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2191	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
537-46-2	Methamphetamine	CC(Cc1ccccc1)NC	0.1056	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1056	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
106-48-9	4-Chlorophenol	Oc1ccc(Cl)cc1	1	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
131860-33-8	Azoxystrobin	COC=C(c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1)C(=O)OC	0.3025	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	6.67%	0.00%	93.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	0.3025	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	Out of Domain
57-42-1	Meperidine (Pethidine)	CCOC(=O)C1(c2ccccc2)CCN(C)CC1	0.1034	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	76.92%	0.00%	23.08%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1034	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*364-85-4	Medazepam	CN1CCN=C(c2ccccc2)c2cc(Cl)ccc12	0.0789	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	66.67%	0.00%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0789	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
10262-69-8	Maprotiline	CNCCCC12CCC(c3ccccc13)c1ccccc21	0.1478	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	0.00%	63.64%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1478	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
18691-97-9	Methabenzthiazuron	CNC(=O)N(C)C1=Nc2ccccc2S1	0.0683	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0683	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
61337-67-5	Mirtazapine	CN1CCN2C(C1)c1ccccc1Cc1cccnc21	0.125	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	30.00%	10.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	0.125	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
*-63-5	Terbutylazine CGA 324007	 																													
139-40-2	Propazine	CC(C)Nc1nc(NC(C)C)nc(Cl)n1	0.1089	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	60.00%	0.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1089	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
17617-23-1	Flurazepam	CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc12	0.1826	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	52.94%	5.88%	41.18%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1826	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
54063-53-5	Propafenone	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	0.2913	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	53.33%	0.00%	46.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2913	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
519-09-5	Benzoylecgonine	CN1C2CCC1CC{P+}(OC(=O)c1ccccc1)C{P+}2C(O)=O	0.5013	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	12.50%	37.50%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5013	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
7374-53-0	Propazine-2-hydroxy	CC(C)Nc1nc(NC(C)C)nc(O)n1	0.066	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.00%	40.00%	20.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.066	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1893-33-0	Pipamperone	NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	0.0678	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	63.64%	4.55%	31.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.0678	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
125-59-7	Phenytoin	O=C1C(c2ccccc2)(c2ccccc2)NC(=O)N1	0.0451	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.0451	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
122-09-8	Phentermine	CC(C)(N)Cc1ccccc1	0.2905	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.2905	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
1609-66-1	Norfentanyl	CCc1cccc(CC)c1N(COC)C(=O)CCl	0.3429	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	53.85%	0.00%	46.15%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha-Activated Haloalkanes,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.3429	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
1418095-19-8	S-Metolachlor NOA 413173	CCc1cccc(C)c1N(C{P-}(C)C(O)=O)C(=O)CS(O)(=O)=O	0.6667	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	35.29%	0.00%	64.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.6667	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
77-17-8	Normeperidine (Norpethidine)	CCOC(=O)C1(c2ccccc2)CCNCC1	0.0969	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0969	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
359-83-1	Pentazocine	CC{P-}1C{P-}2Cc3ccc(O)cc3C{P-}1(C)CCN2CC=C(C)C	0.3116	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	26. Phenolic Derivatives	In domain	25.00%	6.25%	68.75%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"Alfa,Beta-Unsaturated Aldehydes"	Undetermined (0 <n< 10)	 	0.3116	in vivo Liver Clastogen positive	Interaction with DNA 	"Alfa,Beta-Unsaturated Aldehydes"	Undetermined (0 <n< 10)	 	 	Out of Domain
144598-75-4	Paliperidone (9-Hydroxyrisperidone)	CC1=C(CCN2CCC(C3c4ccc(F)cc4ON=3)CC2)C(=O)N2CCCC{P-}(O)C2=N1	0.2093	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.77%	3.85%	65.38%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2093	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
28721-07-5	Oxcarbazepine	NC(=O)N1c2ccccc2CC(=O)c2ccccc12	0.2789	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	11.11%	0.00%	88.89%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2789	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
*-65-0	Terbutylazine SYN 545666	 																													
315-72-0	Opipramol	OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc23)CC1	0.305	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	58.82%	11.76%	29.41%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.305	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
132539-06-1	Olanzapine	CC1=CC2=C(Nc3ccccc3N=C2N2CCN(C)CC2)S1	0.1921	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	17.65%	0.00%	82.35%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	0.1921	in vivo Liver Clastogen positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
93413-62-8	O-Desmethylvenlafaxine (Desvenlafaxine)	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	0.2806	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 26. Phenolic Derivatives	In domain	64.29%	14.29%	21.43%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2806	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
73986-53-5	O-Desmethyltramadol	CN(C)CC1CCCCC1(O)c1cccc(O)c1	0.3599	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	 	In domain	53.85%	15.38%	30.77%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3599	in vivo Liver Clastogen negative	 	Substituted Phenols	 	 	 	Out of Domain
75596-99-5	Metalaxyl NOA 409045	 																													
1173021-76-5	S-Metolachlor CGA 368208	CCc1cccc(C)c1NC(=O)CS(O)(=O)=O	0.5	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	Belongs to deacivated path	53. Carboxylic acid amines	In domain	25.00%	0.00%	75.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"Substituted Phenols,Carboxylic Acid Amides"	Undetermined (0 <n< 10)	Belongs to deacivated path	0.5	in vivo Liver Clastogen negative	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	Belongs to deacivated path	53. Carboxylic acid amines	Out of Domain
37115-43-8	alpha-Hydroxyalprazolam	OCC1=NN=C2CN=C(c3ccccc3)c3cc(Cl)ccc3N12	0.1549	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	38.46%	0.00%	61.54%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1549	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
34084-50-9	7-Aminoflunitrazepam	CN1C(=O)CN=C(c2ccccc2F)c2cc(N)ccc12	0.2951	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Anilines	 	Belongs to deacivated path	* 7. Single Ring Aromatic Amines	In domain	54.55%	9.09%	36.36%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.2951	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
15307-79-6	Diclofenac	OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	0.5984	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	N-Substituted Aromatic Amines	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5984	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
6703-27-1	Acetylcodeine	CC(=O)OC{P-}1C=CC2C{P-}3Cc4ccc(OC)c5c4C{P+}2(CCN3C)C{P-}1O5	0.1137	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Specific Acetate Esters	 	 	 	In domain	50.00%	0.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1137	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
125-71-3	Dextromethorphan (Methorphan)	CN1CCC{P+}23CCCCC{P+}2C{P-}1Cc1ccc(OC)cc31	0.2423	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	73.33%	0.00%	26.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2423	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
2886-65-9	Desalkylflurazepam	O=C1C=NC(c2ccccc2F)=C2C=C(Cl)C=CC2=N1	0.3593	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3593	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
71195-58-9	Alfentanil	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCN2C(=O)N(CC)N=N2)CC1	0.1086	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	44.00%	8.00%	48.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.1086	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
529-38-4	Cocaethylene	CCOC(=O)C{P+}1C{P-}2CCC{P-}(CC{P+}1OC(=O)c1ccccc1)N2C	0.2247	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	55.56%	16.67%	27.78%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2247	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
76-57-3	Codeine	CN1CCC{P-}23C{P-}4C=CC{P+}(O)C{P+}2Oc2c3c(CC{P-}14)ccc2OC	0.2697	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	41.18%	0.00%	58.82%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2697	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
114798-26-4	Losartan	CCCCC1=NC(Cl)=C(CO)N1Cc1ccc(-c2ccccc2C2=NNN=N2)cc1	0.2986	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	Belongs to deacivated path	* 29. Unsaturated Compounds	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2986	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
59468-90-5	alpha-Hydroxymidazolam	OCC1=NC=C2CN=C(c3ccccc3F)c3cc(Cl)ccc3N12	0.3428	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	21.43%	0.00%	78.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3428	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
30223-73-5	EDDP (metabolite of Methadone)	CC=C1C(c2ccccc2)(c2ccccc2)CC(C)N1C	0.0983	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	18.18%	0.00%	81.82%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0983	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
37115-45-0	alpha-Hydroxytriazolam	OCC1=NN=C2CN=C(c3ccccc3Cl)c3cc(Cl)ccc3N12	0.3001	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	21.43%	0.00%	78.57%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3001	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
113-59-7	Chlorprothixene	CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc12	0.2151	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	18.18%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2151	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
71675-85-9	Amisulpride	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	0.2806	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Substituted Anilines"	 	Belongs to deacivated path	* 3. Single Ring Aromatic Amines;* 52. Carboxylic acid amines	In domain	40.00%	10.00%	50.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Single-ring Substituted Primary Aromatic Amines,DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Substituted Anilines"	 	Belongs to deacivated path	0.2806	in vivo Liver Clastogen negative	 	"Single-ring Substituted Primary Aromatic Amines,DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Substituted Anilines"	 	Belongs to deacivated path	* 3. Single Ring Aromatic Amines;* 52. Carboxylic acid amines	Out of Domain
50-48-6	Amitriptyline	CN(C)CCC=C1c2ccccc2CCc2ccccc12	0.1504	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	27.27%	9.09%	63.64%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1504	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
139481-59-7	Candesartan	CCOC1=Nc2cccc(C(O)=O)c2N1Cc1ccc(-c2ccccc2C2NN=NN=2)cc1	0.2003	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	16.67%	0.00%	83.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2003	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
101224-22-0	Buprenorphine glucuronide	CC(C)(C)C{P+}(C)(O)C{P-}1CC{P-}23CCC{P-}1(OC)C{P-}1C{P-}22CCN(CC4CC4)C{P+}3Cc3ccc(OC{P-}4C{P+}(O)C{P-}(O)C{P+}(O)C{P-}(C(O)=O)O4)c(c23)O1	0.3825	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	51.22%	4.88%	43.90%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3825	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
14028-44-5	Amoxapine	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	0.2248	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	8.33%	0.00%	91.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2248	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
300-62-9	Amphetamine	CC(N)Cc1ccccc1	0.1253	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	60.00%	0.00%	40.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1253	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
5786-21-0	Clozapine	CN1CCN(C2c3ccccc3Nc3ccc(Cl)cc3N=2)CC1	0.1744	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.77%	0.00%	69.23%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1744	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
60282-87-3	Gestoden	CCC{P+}12CCC{P-}3C{P-}(CCC4=CC(=O)CCC{P+}34)C{P+}1C=CC{P+}2(O)C#C	0.2846	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	In domain	56.52%	8.70%	34.78%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Epoxides and Aziridines	 	 	0.2846	in vivo Liver Clastogen negative	 	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	 	 	 	Out of Domain
6740-88-1	Ketamine	CNC{P+}1(c2ccccc2Cl)CCCCC1=O	0.3501	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	45.45%	0.00%	54.55%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3501	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
209414-07-3	JWH-018 (N-(n-pentanoic acid)	CCCCCN1C=C(C(=O)c2cccc3ccccc23)c2ccccc12	0.2268	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	Belongs to deacivated path	29. Unsaturated Compounds	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.2268	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
138402-11-6	Irbesartan	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C2NN=NN=2)cc1	0.2367	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	31.82%	0.00%	68.18%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2367	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
*733340-70-3	Iopromid	CN(CC(O)CO)C(=O)c1c(I)c(NC(=O)COC)c(I)c(C(=O)NCC(O)CO)c1I	0.1774	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"DNA Intercalators with Carboxamide and Aminoalkylamine Side Chain,Carboxylic Acid Amides"	 	Belongs to deacivated path	* 52. Carboxylic acid amines	Out of domain	59.26%	0.00%	40.74%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.1774	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
117428-22-5	Picoxystrobin	COC=C(c1ccccc1COc1cccc(C(F)(F)F)n1)C(=O)OC	0.4314	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Geminal Polyhaloalkane Derivatives,alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Geminal Polyhaloalkane Derivatives,alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	0.4314	in vivo Liver Clastogen negative	 	"Geminal Polyhaloalkane Derivatives,alpha,beta-Unsaturated Carboxylic Acids and Esters"	 	 	 	Out of Domain
252913-85-2	Trifloxystrobin CGA 321113	CC(c1cccc(C(F)(F)F)c1)=N/OCc1ccccc1C(/C(O)=O)=N/OC	0.1158	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Geminal Polyhaloalkane Derivatives	 	 	0.1158	in vivo Liver Clastogen negative	 	Geminal Polyhaloalkane Derivatives	 	 	 	Out of Domain
50-49-7	Imipramine	CN(C)CCCN1c2ccccc2CCc2ccccc12	0.1715	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	45.45%	9.09%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1715	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
466-99-9	Hydromorphone	CN1CCC23C4CCC(=O)C2Oc2c3c(CC14)ccc2O	0.1837	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives	In domain	43.75%	0.00%	56.25%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1837	in vivo Liver Clastogen negative	 	Substituted Phenols	 	Belongs to deacivated path	* 20. Phenolic Derivatives	Out of Domain
113-53-1	Dothiepin	CN(C)CCC=C1c2ccccc2CSc2ccccc12	0.1879	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	27.27%	9.09%	63.64%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1879	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
52-86-8	Haloperidol	OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	0.6566	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	56.25%	6.25%	37.50%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.6566	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
1668-19-5	Doxepin	CN(C)CCC=C1c2ccccc2COc2ccccc12	0.1989	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	9.09%	54.55%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.1989	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
64744-50-9	Gabapentin-lactam	O=C1CC2(CCCCC2)CN1	0.5218	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	72.73%	0.00%	27.27%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.5218	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
768-94-5	1-Adamantylamin	NC12CC3CC(C1)CC(C2)C3	0.963	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	81.82%	0.00%	18.18%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.963	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
14089-52-2	"3,4-Methylenedioxyethamphetamine (MDEA)"	CCNC(C)Cc1ccc2c(c1)OCO2	0.2251	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	60.00%	10.00%	30.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	0.2251	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Hydroxylated phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
78755-81-4	Flumazenil	CCOC(=O)C1=C2CN(C)C(=O)c3cc(F)ccc3N2C=N1	0.1182	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	17.65%	0.00%	82.35%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1182	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
4959-17-5	7-Aminoclonazepam	Nc1ccc2c(c1)C(c1ccccc1Cl)=NCC(=O)N2	0.6778	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Carboxylic Acid Amides,Substituted Anilines"	 	Belongs to deacivated path	* 53. Carboxylic acid amines;* 7. Single Ring Aromatic Amines;* 9. Single Ring Aromatic Amines	In domain	30.00%	10.00%	60.00%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Carboxylic Acid Amides,Substituted Anilines"	 	Belongs to deacivated path	0.6778	in vivo Liver Clastogen negative	 	"Carboxylic Acid Amides,Substituted Anilines"	 	Belongs to deacivated path	* 53. Carboxylic acid amines;* 7. Single Ring Aromatic Amines;* 9. Single Ring Aromatic Amines	Out of Domain
25451-15-4	Felbamate	NC(=O)OCC(COC(N)=O)c1ccccc1	0.1722	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	Carbamates	 	 	 	In domain	91.67%	0.00%	8.33%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	"N-HydroxylAmines,Hydroxamic acid"	Undetermined (0 <n< 10)	 	0.1722	in vivo Liver Clastogen positive	Interaction with DNA 	"N-HydroxylAmines,Hydroxamic acid"	Undetermined (0 <n< 10)	 	 	Out of Domain
30043-49-3	Ethidimuron (Sulfadiazole)	CCS(=O)(=O)C1=NN=C(N(C)C(=O)NC)S1	0.061	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	6.25%	0.00%	93.75%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.061	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
75847-73-3	Enalapril	CCOC(=O)C{P-}(CCc1ccccc1)NC{P-}(C)C(=O)N1CCCC{P-}1C(O)=O	0.2855	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	54.55%	4.55%	40.91%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2855	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
469-62-5	Propoxyphene (Dextropropoxyphene)	CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c1ccccc1	0.0944	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	53.33%	13.33%	33.33%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0944	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
58955-93-4	"10,11-Dihydro-10,11-dihydroxycarbamazepine"	NC(=O)N1c2ccccc2C{P+}(O)C{P-}(O)c2ccccc12	0.3981	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.3981	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
355-46-4	Perfluorohexane sulfonate (PFHxS) (anion)	OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
82626-48-0	Zolpidem	CC1=CN2C(CC(=O)N(C)C)=C(c3ccc(C)cc3)N=C2C=C1	0.1055	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1055	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
43200-80-2	Zopiclone	CN1CCN(C(=O)OC2c3c(C(=O)N2c2ccc(Cl)cn2)nccn3)CC1	0.1102	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	In domain	23.53%	0.00%	76.47%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	0.1102	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Heterocyclic Aromatic Amines	Undetermined (0 <n< 10)	 	 	Out of Domain
1420-07-1	Dinoterb	CC(C)(C)c1cc(N(=O)=O)cc(N(=O)=O)c1O	0.4419	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	 	 	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitroaniline Derivatives,Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Substituted Anilines"	 	 	0.4419	in vivo Liver Clastogen negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	 	 	Out of Domain
143-24-8	Tetraglyme	COCCOCCOCCOCCOC	0.0492	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	100.00%	0.00%	0.00%	In domain	In domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0492	in vivo Liver Clastogen negative	 	 	 	 	 	In domain
51235-04-2	Hexazinon	CN(C)C1=NC(=O)N(C2CCCCC2)C(=O)N1C	0.0836	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	27.78%	0.00%	72.22%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	0.0836	in vivo Liver Clastogen positive	Interaction with DNA 	N-HydroxylAmines	Undetermined (0 <n< 10)	 	 	Out of Domain
*-70-6	Dimethachlor CGA 369873	CC(C)(C)C{P+}(C)(O)C{P-}1CC{P-}23CCC{P-}1(OC)C{P-}1C{P-}22CCN(CC4CC4)C{P+}3Cc3ccc(OC{P-}4C{P+}(O)C{P-}(O)C{P+}(O)C{P-}(C(O)=O)O4)c(c23)O1	0.3825	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	51.22%	4.88%	43.90%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	Substituted Phenols	 	 	0.3825	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
4184-79-6	"5,6-Dimethylbenzotriazole"	Cc1cc2c(cc1C)NN=N2	1	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	1	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
164265-78-5	Valsartan acid	OC(=O)c1ccc(-c2ccccc2C2=NNN=N2)cc1	0.221	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.221	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
17254-80-7	Chloridazon-methyl-desphenyl	CN1C(=O)C(Cl)=C(N)C=N1	0.1984	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	0.1984	in vivo Liver Clastogen positive	Interaction with DNA 	Polarised Haloalkenes Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
137862-53-4	Valsartan	CCCCC(=O)N(Cc1ccc(-c2ccccc2C2NN=NN=2)cc1)C(C(C)C)C(O)=O	0.2119	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	40.91%	0.00%	59.09%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2119	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
148553-50-8	Pregabalin	CCOP(=S)(OCC)ON=C(C#N)c1ccccc1	0.3002	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3002	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
3622-35-3	Benzothiazole-6-carboxylic acid	OC(=O)c1ccc2c(c1)SC=N2	0.1868	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.1868	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
16118-49-3	Carbetamide	CCNC(=O)C(C)OC(=O)Nc1ccccc1	0.1483	No data	in vivo Liver Clastogen negative	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	Belongs to deacivated path	53. Carboxylic acid amines	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	0.1483	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
*-71-4	Methyl-1H-benzotriazole (mix of isomers 4- and 5-)	CC1=CC=CC2C1=NNN=2_CC1=CC2C(C=C1)=NNN=2	0.4973	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.4973	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
2163-68-0	Atrazine-2-hydroxy	CCNc1nc(NC(C)C)nc(O)n1	0.086	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	33.33%	44.44%	22.22%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.086	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*513-08-3	Tri-n-propyl phosphate (TnPP)	CCCOP(=O)(OCCC)OCCC	0.1764	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	In domain	78.57%	0.00%	21.43%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	0.1764	in vivo Liver Clastogen negative	 	"Alkylphosphates, Alkylthiophosphates and Alkylphosphonates"	 	 	 	Out of Domain
33665-90-6	Acesulfame	CC1=CC(=O)NS(=O)(=O)O1	0.1955	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	0.1955	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	"alpha,beta-Unsaturated Carbonyls and Related Compounds"	Undetermined (0 <n< 10)	 	 	Out of Domain
375-73-5	Perfluorobutanesulfonate (PFBS)	OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interaction with DNA 	Geminal Polyhaloalkane Derivatives	Undetermined (0 <n< 10)	 	 	Out of Domain
438-60-8	Protriptyline	CNCCCC1c2ccccc2C=Cc2ccccc12	0.2098	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	20.00%	0.00%	80.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2098	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
101-21-3	Chlorpropham	CC(C)OC(=O)Nc1cccc(Cl)c1	0.3165	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	In domain	22.22%	0.00%	77.78%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	"Carbamates,Substituted Phenols"	Undetermined (0 <n< 10)	 	0.3165	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carbamates	Undetermined (0 <n< 10)	 	 	Out of Domain
1231244-60-2	Metazachlor OA	Cc1cccc(C)c1N(CN1C=CC=N1)C(=O)C(O)=O	0.2315	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	0.00%	0.00%	100.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2315	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
111974-69-7	Quetiapine	OCCOCCN1CCN(C2c3ccccc3Sc3ccccc3N=2)CC1	0.222	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	47.06%	5.88%	47.06%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	0.222	in vivo Liver Clastogen positive	Interaction with DNA 	Dicarbonyl Compounds	Undetermined (0 <n< 10)	 	 	Out of Domain
106266-06-2	Risperidone	CC1=C(CCN2CCC(C3c4ccc(F)cc4ON=3)CC2)C(=O)N2CCCCC2=N1	0.1186	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.00%	4.00%	68.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.1186	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
19395-41-6	Ritalinic acid	OC(=O)C(C1CCCCN1)c1ccccc1	0.2991	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	54.55%	0.00%	45.45%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.2991	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
172960-62-2	Metazachlor ESA (BH 479-8)	Cc1cccc(C)c1N(CN1C=CC=N1)C(=O)CS(O)(=O)=O	0.5	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	11.76%	0.00%	88.24%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.5	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
79617-96-2	Sertraline	CNC{P-}1CCC{P-}(c2ccc(Cl)c(Cl)c2)c2ccccc12	0.3917	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	30.00%	0.00%	70.00%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3917	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
66-28-4	Strophanthidin	CC{P+}12CCC{P-}3C{P-}(CCC{P+}4(O)CC{P-}(O)CCC{P+}34C=O)C{P+}1(O)CCC{P+}2C1COC(=O)C=1	0.871	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	62.07%	3.45%	34.48%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.871	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
88-85-7	Dinoseb	CCC(C)c1cc(N(=O)=O)cc(N(=O)=O)c1O	0.3633	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	Belongs to deacivated path	* 20. Phenolic Derivatives	In domain	58.33%	0.00%	41.67%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	Belongs to deacivated path	0.3633	in vivo Liver Clastogen negative	 	"Nitrophenols, Nitrophenyl Ethers and Nitrobenzoic Acids,Polynitroarenes"	 	Belongs to deacivated path	* 20. Phenolic Derivatives	Out of Domain
21725-46-2	Cyanazine (Fortrol)	CCNc1nc(NC(C)(C)C#N)nc(Cl)n1	0.3281	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	36.36%	36.36%	27.27%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.3281	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
15676-16-1	Sulpirid	CCN{+}1CCCC{P-}1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	In domain	33.33%	0.00%	66.67%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Arenesulphonamides	Undetermined (0 <n< 10)	 	 	Out of Domain
25653-16-1	"Tris(3,5-dimethylphenyl)phosphate (T35DMPP)"	Cc1cc(C)cc(OP(=O)(Oc2cc(C)cc(C)c2)Oc2cc(C)cc(C)c2)c1	0.2412	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	14.29%	0.00%	85.71%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2412	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
144701-48-4	Telmisartan	CCCC1=Nc2c(C)cc(C3=Nc4ccccc4N3C)cc2N1Cc1ccc(-c2ccccc2C(O)=O)cc1	0.2415	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	26.32%	0.00%	73.68%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2415	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
3734-33-6	Denatonium	CCN{+}(CC)(Cc1ccccc1)CC(=O)Nc1c(C)cccc1C	N/A	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	In domain	35.71%	0.00%	64.29%	Out of domain	Out of Domain	 	 	 	 	 	 	N/A	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Carboxylic Acid Amides	Undetermined (0 <n< 10)	 	 	Out of Domain
97240-79-4	Topiramate	CC1(C)OC{P+}2COC{P+}3(COS(N)(=O)=O)C{P+}(C{P+}2O1)OC(C)(C)O3	0.0969	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	22.73%	0.00%	77.27%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.0969	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
*-73-5	Dimethachlor sulfonic acid CGA 354742	 																													
19794-93-5	Trazodone	O=C1N(CCCN2CCN(c3cccc(Cl)c3)CC2)N=C2C=CC=CN12	0.3983	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	28.57%	4.76%	66.67%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.3983	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
28911-01-5	Triazolam	CC1=NN=C2CN=C(c3ccccc3Cl)c3cc(Cl)ccc3N12	0.2111	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	15.38%	0.00%	84.62%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	0.2111	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	Substituted Phenols	Undetermined (0 <n< 10)	 	 	Out of Domain
87674-68-8	Dimethenamid	CC(COC)N(C(=O)CCl)C1=C(C)SC=C1C	0.1634	No data	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	In domain	29.41%	0.00%	70.59%	Out of domain	Out of Domain	in vivo Liver Clastogen positive	in vitro CA positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	0.1634	in vivo Liver Clastogen positive	Interactions with topoisomerases / proteins	alpha-Activated Haloalkanes	Undetermined (0 <n< 10)	 	 	Out of Domain
54-11-5	Nicotine	CN1CCCC1c1cccnc1	0.4037	No data	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	 	In domain	71.43%	0.00%	28.57%	Out of domain	Out of Domain	in vivo Liver Clastogen negative	in vitro CA negative	 	 	 	 	0.4037	in vivo Liver Clastogen negative	 	 	 	 	 	Out of Domain
